USPatent applicationPatented

Heteroleptic iridium complexes as dopants

Granted 29 Apr 2014 · 3 office actions

Assignee: Universal Display

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Zeinab Elshenawy, Alan DeAngelis, Nasrin Ansari, Chuanjun Xia +1 · Examiner: Marie R. Yamnitzky · AU 1786 · TC 1700

Life of the application

13 dated events
⤢ drag to zoom20122014201620182020202220242026202820302032ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

Novel phosphorescent heteroleptic iridium complexes with phenylpyridine and dibenzo-containing ligands are provided. Alkyl substitution at specific positions on the ligands gives rise to compounds with improved OLED properties, including saturated green emission.

Description

21 parts
›The claimed invention was made by, on behalf…

The claimed invention was made by, on behalf of, and/or in connection with one or more of the following parties to a joint university corporation research agreement: Regents of the University of Michigan, Princeton University, The University of Southern California, and the Universal Display Corporation. The agreement was in effect on and before the date the claimed invention was made, and the claimed invention was made as a result of activities undertaken within the scope of the agreement.

›FIELD OF THE INVENTION

The present invention relates to heteroleptic iridium complexes suitable for inclusion in OLED devices.

›BACKGROUND

Opto-electronic devices that make use of organic materials are becoming increasingly desirable for a number of reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials. For example, the wavelength at which an organic emissive layer emits light may generally be readily tuned with appropriate dopants.

OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.

One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Color may be measured using CIE coordinates, which are well known to the art.

One example of a green emissive molecule is tris(2-phenylpyridine) iridium, denoted Ir(ppy) 3 , which has the following structure:

In this, and later figures herein, we depict the dative bond from nitrogen to metal (here, Ir) as a straight line.

As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large. Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.

As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.

As used herein, “solution processible” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.

A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.

As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.

As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.

More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.

›SUMMARY OF THE INVENTION

In one aspect, a compound having the formula:

is provided. R 1 and R 2 are optionally linked and the sum of the number of carbon atoms in R 1 and R 2 is at least 2. R 3 , R 4 , R 5 , R 6 are optionally linked, and R a and R b represent mono-, di-, tri- or tetra-substitution. X is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO 2 , CRR′, SiRR′, and GeRR′, and R a , R b , R, R′, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfanyl, sulfonyl, phosphino, and combinations thereof; and wherein n is 1 or 2.

In one aspect, n is 2. In one aspect, X is O. In one aspect, R 1 is hydrogen and R 2 is alkyl. In another aspect, R 1 is alkyl and R 2 is hydrogen. In one aspect, R 1 and R 2 are alkyl. In one aspect, R 1 and R 2 contain one or more deuterium atoms. In another aspect, R 1 or R 2 are independently selected from the group consisting of branched alkyl, cyclic alkyl, bicyclic alkyl, and multicyclic alkyl. In one aspect, R 1 or R 2 is iso-propyl.

In one aspect, R 1 or R 2 contain one or more deuterium atoms. In one aspect, R 3 , R 4 , R 5 and R 6 are independently selected from the group consisting of hydrogen, deuterium, alkyl, aryl, and combinations thereof. In another aspect, at least one of R 3 , R 4 , R 5 and R 6 comprises a branched alkyl, cyclic alkyl, bicyclic alkyl, or a multicyclic alkyl. In one aspect, R 3 , R 4 , R 5 or R 6 contain one or more deuterium atoms.

In one aspect, the compound is selected from the group consisting of Compound 53, Compounds 157-159, Compound 165, Compound 174, Compound 175, Compounds 184-185, Compound 314, Compound 321, Compounds 625-628, Compound 633, Compound 643, Compounds 652-653, and Compounds 1145-1146.

In one aspect, a first device is provided. The first device comprises a first organic light-emitting device, further comprising an anode, a cathode, and an organic layer, disposed between the anode and the cathode, comprising a compound having the formula:

R 1 and R 2 are optionally linked and the sum of the number of carbon atoms in R 1 and R 2 is at least 2. R 3 , R 4 , R 5 , R 6 are optionally linked, and R a and R b represent mono-, di-, tri- or tetra-substitution. X is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO 2 , CRR′, SiRR′, and GeRR′, and R a , R b , R, R′, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein n is 1 or 2.

In one aspect, the first device is a consumer product. In another aspect, the first device is an organic light-emitting device. In another aspect, the first device comprises a lighting panel. In one aspect, the organic layer is an emissive layer and the compound is an emissive dopant. In another aspect, the organic layer is an emissive layer and the compound is a non-emissive dopant.

In one aspect, the organic layer further comprises a host. In another aspect, the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan, wherein any substituent in the host is an unfused substituent independently selected from the group consisting of C n H 2n+1 , OC n H 2n+1 , OAr 1 , N(C n H 2n+1 ) 2 , N(Ar 1 )(Ar 2 ), CH═CH—C n H 2n+1 , C≡CC n H 2n+1 , Ar 1 , Ar 1 —Ar 2 , C n H 2n —Ar 1 , or no substitution, wherein Ar 1 and Ar 2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof, and wherein n is from 1 to 10.

In one aspect, the host has the formula

In another aspect, the host is selected from the group consisting of:

and combinations thereof.

In one aspect, the host is a metal complex.

›BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows an organic light emitting device.

FIG. 2 shows an inverted organic light-emitting device that does not have a separate electron transport layer.

FIG. 3 shows a compound of Formula I.

›DETAILED DESCRIPTION · 1 of 4

Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.

The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.

More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), which are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.

FIG. 1 shows an organic light emitting device 100 . The figures are not necessarily drawn to scale. Device 100 may include a substrate 110 , an anode 115 , a hole injection layer 120 , a hole transport layer 125 , an electron blocking layer 130 , an emissive layer 135 , a hole blocking layer 140 , an electron transport layer 145 , an electron injection layer 150 , a protective layer 155 , and a cathode 160 . Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164 . Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which are incorporated by reference.

More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F.sub.4-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.

FIG. 2 shows an inverted OLED 200 . The device includes a substrate 210 , a cathode 215 , an emissive layer 220 , a hole transport layer 225 , and an anode 230 . Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has a cathode disposed over the anode, and device 200 has cathode 215 disposed under anode 230 , device 200 may be referred to as an “inverted” OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200 . FIG. 2 provides one example of how some layers may be omitted from the structure of device 100 .

The simple layered structure illustrated in FIGS. 1 and 2 is provided by way of non-limiting example, and it is understood that embodiments of the invention may be used in connection with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be achieved by combining the various layers described in different ways, or layers may be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe various layers as comprising a single material, it is understood that combinations of materials, such as a mixture of host and dopant, or more generally a mixture, may be used. Also, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200 , hole transport layer 225 transports holes and injects holes into emissive layer 220 , and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an “organic layer” disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to FIGS. 1 and 2 .

›DETAILED DESCRIPTION · 2 of 4

Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in FIGS. 1 and 2 . For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Forrest et al., and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entireties.

Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. patent application Ser. No. 10/233,470, now U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink jet and OVJD. Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons is a preferred range. Materials with asymmetric structures may have better solution processibility than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.

Devices fabricated in accordance with embodiments of the invention may be incorporated into a wide variety of consumer products, including flat panel displays, computer monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads up displays, fully transparent displays, flexible displays, laser printers, telephones, cell phones, personal digital assistants (PDAs), laptop computers, digital cameras, camcorders, viewfinders, micro-displays, vehicles, a large area wall, theater or stadium screen, or a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present invention, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25 degrees C.).

The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.

The terms halo, halogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryalkyl, heterocyclic group, aryl, aromatic group, and heteroaryl are known to the art, and are defined in U.S. Pat. No. 7,279,704 at cols. 31-32, which are incorporated herein by reference.

In one embodiment, a compound having the formula:

is provided. R 1 and R 2 are optionally linked and the sum of the number of carbon atoms in R 1 and R 2 is at least 2. Thus, both R 1 and R 2 both represent a substituent with at least one carbon. If R 1 does not represent substituent containing carbon, then R 2 must represent a substituent containing at least two carbons and vice versa. R 3 , R 4 , R 5 , R 6 are optionally linked, and R a and R b represent mono-, di-, tri- or tetra-substitution. X is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO 2 , CRR′, SiRR′, and GeRR′, and R a , R b , R, R′, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein n is 1 or 2.

In one embodiment, n is 2. In one embodiment, X is O. In one embodiment, R 1 is hydrogen and R 2 is alkyl. In another embodiment, R 1 is alkyl and R 2 is hydrogen. In one embodiment, R 1 and R 2 are alkyl. In another embodiment, R 1 or R 2 are independently selected from the group consisting of branched alkyl, cyclic alkyl, bicyclic alkyl, and multicyclic alkyl. In one embodiment, R 1 or R 2 is iso-propyl. Substitution at the 4- and 5-positions of either pyridine ring in the compounds of Formula I can give rise to compounds with desirable properties such as saturated green emission, high efficiencies, and long device lifetimes when incorporated in OLED devices. The photophysical and device properties of devices incorporating these compounds may be tuned by varying the nature of the substituent at the 4- or 5-position on the pyridine. The 4-position on a pyridine ring in the compound of Formula I is the position occupied by the R 5 or R 1 substituent, whereas the 5-position is the position occupied by the R 4 or R 2 substituent.

›DETAILED DESCRIPTION · 3 of 4

As used herein, fragments containing the following structure:

are called DBX groups, i.e. dibenzo X, where X is any of the atoms or groups described herein. Atoms A1-A8 can comprise nitrogen or carbon.

In one embodiment, R 1 or R 2 contain one or more deuterium atoms. In one embodiment, R 1 and R 2 contain one or more deuterium atoms. In one embodiment, R 3 , R 4 , R 5 and R 6 are independently selected from the group consisting of hydrogen, deuterium, alkyl, aryl, and combinations thereof. In another embodiment, at least one of R 3 , R 4 , R 5 and R 6 comprises a branched alkyl, cyclic alkyl, bicyclic alkyl, or a multicyclic alkyl. In one embodiment, R 3 , R 4 , R 5 or R 6 contain one or more deuterium atoms. Without being bound by theory, incorporation of deuterium is thought to improve stability of compounds due the greater bond strength of the carbon-deuterium (C-D) bond versus the carbon-hydrogen (C—H) bond. Therefore, compounds wherein labile C—H bonds are replaced by C-D bonds, higher stability can be expected. Without being bound by theory, it is believed that incorporation of deuterium atoms on the alkyl groups of ligands for iridium complexes, the resulting complexes can have longer device lifetimes.

In one embodiment, the compound is selected from the group consisting of:

Compound 53

Compound 157

Compound 158

Compound 159

Compound 165

Compound 174

Compound 175

Compound 184

Compound 185

Compound 314

Compound 321

Compound 625

Compound 626

Compound 627

Compound 628

Compound 633

Compound 643

Compound 652

Compound 653

Compound 1145

Compound 1146

In one embodiment, suitable R 1 -R 6 groups in the compounds of Formula I include the configurations of substituents in Table 1.

In one embodiment, a first device is provided. The first device comprises a first organic light emitting device, further comprising an anode, a cathode, and an organic layer, disposed between the anode and the cathode, comprising a compound having the formula:

R 1 and R 2 are optionally linked and the sum of the number of carbon atoms in R 1 and R 2 is at least 2. R 3 , R 4 , R 5 , R 6 are optionally linked, and R a and R b represent mono-, di-, tri- or tetra-substitution. X is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO 2 , CRR′, SiRR′, and GeRR′, and R a , R b , R, R′, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein n is 1 or 2.

In one embodiment, the first device is a consumer product. In another embodiment, the first device is an organic light-emitting device. In another embodiment, the first device comprises a lighting panel. In one embodiment, the organic layer is an emissive layer and the compound is an emissive dopant. In another embodiment, the organic layer is an emissive layer and the compound is a non-emissive dopant.

In one embodiment, the organic layer further comprises a host. In another embodiment, the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan, wherein any substituent in the host is an unfused substituent independently selected from the group consisting of C n H 2n+1 , OC n H 2n+1 , OAr 1 , N(C n H 2n+1 ) 2 , N(Ar 1 )(Ar 2 ), CH═CH—C n H 2n+1 , C≡CC n H 2n+1 , Ar 1 , Ar 1 —Ar 2 , C n H 2n —Ar 1 , or no substitution, wherein Ar 1 and Ar 2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof, and wherein n is from 1 to 10.

In one embodiment, the host has the formula

In another embodiment, the host is selected from the group consisting of:

and combinations thereof.

In one embodiment, the host is a metal complex.

Device Examples

All example devices were fabricated by high vacuum (<10 −7 Torr) thermal evaporation (VTE). The anode electrode is 1200 Å of indium tin oxide (ITO). The cathode consisted of 10 Å of LiF followed by 1,000 Å of Al. All devices are encapsulated with a glass lid sealed with an epoxy resin in a nitrogen glove box (<1 ppm of H 2 O and O 2 ) immediately after fabrication, and a moisture getter was incorporated inside the package.

The organic stack of the device examples consisted of sequentially, from the ITO surface, 100 Å of Compound C as the hole injection layer (HIL), 300 Å of 4,4′-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (alpha-NPD) as the hole transporting layer (HTL), 300 Å of the invention compound doped in Compound D as host with 5-15 weight percent of a compound of Formula I as the emissive layer (EML), 50 Å of Compound D as blocking layer (BL), and 400 Å of Alq (tris-8-hydroxyquinoline aluminum) as the ETL. Comparative Examples with Compound A and Compound B were fabricated similarly to the Device Examples except that Compound A and Compound B were used as the emitter in the EML.

The device results and data are summarized in Tables 1 from those devices. As used herein, NPD, Alq, Compound A, Compound B, Compound C, and Compound D have the following structures:

Table 3 is a summary of the device data. The luminous efficiency (LE), external quantum efficiency (EQE) and power efficiency (PE) were measured at 1000 nits, while the lifetime (LT 80% ) was defined as the time required for the device to decay to 80% of its initial luminance under a constant current density of 40 mA/cm 2 .

The advantage of alkyl substitution on the 4- and 5-positions of the DBX-pyridine ring is clear from Table 3. Compared to Comparative Example 1, with no substitution at the 4- or 5-positions of the DBX-pyridine ring, the compounds of Formula I are more saturated (lower CIE x coordinate and shorter λ max ) and the broadness as measured by the FWHM is comparable. In all the inventive compounds, the voltage is lower and the LE, PE and EQE values are all higher. In the case of Compounds 53, 158, 175, 633 and 643, the PE is at least twice as high as Comparative Example 1.

›DETAILED DESCRIPTION · 4 of 4

Compared to Comparative Example 2 (Compound B), with only one-carbon substitution (methyl) at the 4-position of the DBX-pyridine ring, Compounds 53, 158, 174, 175, 184, 185, and 314 have more saturated color based CIE x coordinate and Compounds 157, 158, 159, 165, 174, 175, 184, 185, 314, 321 and 626 all have shorter λ max values. Most of the compounds of Formula I have narrower emission profiles (as measured by FWHM) than Comparative Example 2. Compounds 53, 158, 165, 314, 321, 625, 633 and 653 all have lower driving voltages than Comparative Example 2. Most of the compounds of Formula I have greater LE, PE and EQE values than Comparative Example 2.

Combination with Other Materials

The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.

›HIL/HTL · 1 of 2

A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but not limit to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoO x ; a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.

Examples of aromatic amine derivatives used in HIL or HTL include, but not limit to the following general structures:

Each of Ar 1 to Ar 9 is selected from the group consisting aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, azulene; group consisting aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and group consisting 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Wherein each Ar is further substituted by a substituent selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, Ar 1 to Ar 9 is independently selected from the group consisting of:

k is an integer from 1 to 20; X 1 to X 8 is C (including CH) or N; Ar 1 has the same group defined above.

Examples of metal complexes used in HIL or HTL include, but not limit to the following general formula:

M is a metal, having an atomic weight greater than 40; (Y 1 —Y 2 ) is a bidentate ligand, Y 1 and Y 2 are independently selected from C, N, O, P, and S; L is an ancillary ligand; m is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and m+n is the maximum number of ligands that may be attached to the metal.

In one aspect, (Y 1 —Y 2 ) is a 2-phenylpyridine derivative.

In another aspect, (Y 1 —Y 2 ) is a carbene ligand.

In another aspect, M is selected from Ir, Pt, Os, and Zn.

In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc + /Fc couple less than about 0.6 V.

Host:

The light emitting layer of the organic EL device of the present invention preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant.

Examples of metal complexes used as host are preferred to have the following general formula:

M is a metal; (Y 3 —Y 4 ) is a bidentate ligand, Y 3 and Y 4 are independently selected from C, N, O, P, and S; L is an ancillary ligand; m is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and m+n is the maximum number of ligands that may be attached to the metal.

In one aspect, the metal complexes are:

(O—N) is a bidentate ligand, having metal coordinated to atoms O and N.

In another aspect, M is selected from Ir and Pt.

In a further aspect, (Y 3 —Y 4 ) is a carbene ligand.

Examples of organic compounds used as host are selected from the group consisting aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, azulene; group consisting aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and group consisting 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atome, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Wherein each group is further substituted by a substituent selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

›HIL/HTL · 2 of 2

In one aspect, host compound contains at least one of the following groups in the molecule:

R 1 to R 7 is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above.

k is an integer from 0 to 20.

X 1 to X 8 is selected from C (including CH) or N.

›HBL

A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED.

In one aspect, compound used in HBL contains the same molecule used as host described above.

In another aspect, compound used in HBL contains at least one of the following groups in the molecule:

k is an integer from 0 to 20; L is an ancillary ligand, m is an integer from 1 to 3.

›ETL · 1 of 9

Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.

In one aspect, compound used in ETL contains at least one of the following groups in the molecule:

R 1 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, it has the similar definition as Ar's mentioned above.

Ar 1 to Ar 3 has the similar definition as Ar's mentioned above.

k is an integer from 0 to 20.

X 1 to X 8 is selected from C (including CH) or N.

In another aspect, the metal complexes used in ETL contains, but not limit to the following general formula:

(O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L is an ancillary ligand; m is an integer value from 1 to the maximum number of ligands that may be attached to the metal.

In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated.

In addition to and/or in combination with the materials disclosed herein, many hole injection materials, hole transporting materials, host materials, dopant materials, exiton/hole blocking layer materials, electron transporting and electron injecting materials may be used in an OLED. Non-limiting examples of the materials that may be used in an OLED in combination with materials disclosed herein are listed in Table 3 below. Table 3 lists non-limiting classes of materials, non-limiting examples of compounds for each class, and references that disclose the materials.

and

EP1725079A1

Arylamines complexed with metal oxides such as molybdenum and tungsten oxides

SID Symposium Digest, 37, 923 (2006) WO2009018009

p-type semiconducting organic complexes

US20020158242

Metal organometallic complexes

US20060240279

Cross-linkable compounds

US20080220265

Hole transporting materials

Triarylamines (e.g., TPD, α-NPD)

Appl. Phys. Lett. 51, 913 (1987)

US5061569

EP650955

J. Mater. Chem. 3, 319 (1993)

Appl. Phys. Lett. 90, 183503 (2007)

Appl. Phys. Lett. 90, 183503 (2007)

Triarylamine on spirofluorene core

Synth. Met. 91, 209 (1997)

Arylamine carbazole compounds

Adv. Mater. 6, 677 (1994), US20080124572

Triarylamine with (di)benzothiophene/(di) benzofuran

US20070278938, US20080106190

Indolocarbazoles

Synth. Met. 111, 421 (2000)

Isoindole compounds

Chem. Mater. 15, 3148 (2003)

Metal carbene complexes

US20080018221

Phosphorescent OLED host materials

Red hosts

Arylcarbazoles

Appl. Phys. Lett. 78, 1622 (2001)

Metal 8-hydroxyquinolates (e.g., Alq 3 , BAlq)

Nature 395, 151 (1998)

US20060202194

WO2005014551

WO2006072002

Metal phenoxybenzothiazole compounds

Appl. Phys. Lett. 90, 123509 (2007)

Conjugated oligomers and polymers (e.g., polyfluorene)

Org. Electron. 1, 15 (2000)

Aromatic fused rings

WO2009066779, WO2009066778, WO2009063833, US20090045731, US20090045730, WO2009008311, US20090008605, US20090009065

Zinc complexes

WO2009062578

Green hosts

Arylcarbazoles

Appl. Phys. Lett. 78, 1622 (2001)

US20030175553

WO2001039234

Aryltriphenylene compounds

US20060280965

US20060280965

WO2009021126

Donor acceptor type molecules

WO2008056746

Aza-carbazole/DBT/DBF

JP2008074939

Polymers (e.g., PVK)

Appl. Phys. Lett. 77, 2280 (2000)

Spirofluorene compounds

WO2004093207

Metal phenoxybenzooxazole compounds

WO2005089025

WO2006132173

JP200511610

Spirofluorene-carbazole compounds

JP2007254297

JP2007254297

Indolocarbazoles

WO2007063796

WO2007063754

5-member ring electron deficient heterocycles (e.g., triazole, oxadiazole)

J. Appl. Phys. 90, 5048 (2001)

WO2004107822

Tetraphenylene complexes

US20050112407

Metal phenoxypyridine compounds

WO2005030900

Metal coordination complexes (e.g., Zn, Al with N{circumflex over ( )}N ligands)

US20040137268, US20040137267

Blue hosts

Arylcarbazoles

Appl. Phys. Lett, 82, 2422 (2003)

US20070190359

Dibenzothiophene/Di- benzofuran-carbazole compounds

WO2006114966, US20090167162

US20090167162

WO2009086028

US20090030202, US20090017330

Silicon aryl compounds

US20050238919

WO2009003898

Silicon/Germanium aryl compounds

EP2034538A

Aryl benzoyl ester

WO2006100298

High triplet metal organometallic complex

US7154114

Phosphorescent dopants

Red dopants

Heavy metal porphyrins (e.g., PtOEP)

Nature 395, 151 (1998)

Iridium(III) organometallic complexes

Appl. Phys. Lett. 78, 1622 (2001)

US2006835469

US2006835469

US20060202194

US20060202194

US20070087321

US20070087321

Adv. Mater. 19, 739 (2007)

WO2009100991

WO2008101842

Platinum(II) organometallic complexes

WO2003040257

Osminum(III) complexes

Chem. Mater. 17, 3532 (2005)

Ruthenium(II) complexes

Adv. Mater. 17, 1059 (2005)

Rhenium (I), (II), and (III) complexes

US20050244673

Green dopants

Iridium(III) organometallic complexes

and its derivatives

Inorg. Chem. 40, 1704 (2001)

US20020034656

US7332232

US20090108737

US20090039776

US6921915

US6687266

Chem. Mater. 16, 2480 (2004)

US20070190359

US 20060008670 JP2007123392

Adv. Mater. 16, 2003 (2004)

Angew. Chem. Int. Ed. 2006, 45, 7800

WO2009050290

US20090165846

US20080015355

Monomer for polymeric metal organometallic compounds

US7250226, US7396598

Pt(II) organometallic complexes, including polydentated ligands

Appl. Phys. Lett. 86, 153505 (2005)

Appl. Phys. Lett. 86, 153505 (2005)

Chem. Lett. 34, 592 (2005)

WO2002015645

US20060263635

Cu complexes

WO2009000673

Gold complexes

Chem. Commun. 2906 (2005)

Rhenium(III) complexes

Inorg. Chem. 142, 1248 (2003)

Deuterated organometallic complexes

US20030138657

Organometallic complexes with two or more metal centers

US20030152802

US7090928

Blue dopants

Iridium(III) organometallic complexes

WO2002002714

WO2006009024

US20060251923

US7393599, WO2006056418, US20050260441, WO2005019373

US7534505

US7445855

US20070190359, US20080297033

US7338722

›ETL · 2 of 9

US20020134984

Angew. Chem. Int. Ed. 47, 1 (2008)

Chem. Mater. 18, 5119 (2006)

Inorg. Chem. 46, 4308 (2007)

WO2005123873

WO2005123873

WO2007004380

WO2006082742

Osmium(II) complexes

US7279704

Organometallics 23, 3745 (2004)

Gold complexes

Appl. Phys. Lett. 74, 1361 (1999)

Platinum(II) complexes

WO2006098120, WO2006103874

Exciton/hole blocking layer materials

Bathocuprine compounds (e.g., BCP, BPhen)

Appl. Phys. Lett., 75, 4 (1999)

Appl. Phys. Lett. 79, 449 (2001)

Metal 8-hydroxyquinolates (e.g., BAlq)

Appl. Phys. Lett. 81, 162 (2002)

5-member ring electron deficient heterocycles such as triazole, oxadiazole, imidazole, benzoimidazole

Appl. Phys. Lett. 81, 162 (2002)

Triphenylene compounds

US20050025993

Fluorinated aromatic compounds

Appl. Phys. Lett. 79, 156 (2001)

Phenothiazine-S-oxide

WO2008132805

Electron transporting materials

Anthracene- benzoimidazole compounds

WO2003060956

US20090179554

Aza triphenylene derivatives

US20090115316

Anthracene-benzothiazole compounds

Appl. Phys. Lett. 89, 063504 (2006)

Metal 8-hydroxyquinolates (e.g., Alq 3 , Zrq 4 )

Appl. Phys. Lett. 51, 913 (1987) US7230107

Metal hydroxybenoquinolates

Chem. Lett. 5, 905 (1993)

Bathocuprine compounds such as BCP, BPhen, etc

Appl. Phys. Lett. 91, 263503 (2007)

Appl. Phys. Lett. 79, 449 (2001)

5-member ring electron deficient heterocycles (e.g., triazole, oxadiazole, imidazole, benzoimidazole)

Appl. Phys. Lett. 74, 865 (1999)

Appl. Phys. Lett. 55, 1489 (1989)

Jpn. J. Apply. Phys. 32, L917 (1993)

Silole compounds

Org. Electron. 4, 113 (2003)

Arylborane compounds

J. Am. Chem. Soc. 120, 9714 (1998)

Fluorinated aromatic compounds

J. Am. Chem. Soc. 122, 1832 (2000)

Fullerene (e.g., C60)

US20090101870

Triazine complexes

US20040036077

Zn (N{circumflex over ( )}N) complexes

US6528187

Experimental

Chemical abbreviations used throughout this document are as follows: Cy is cyclohexyl, dba is dibenzylideneacetone, EtOAc is ethyl acetate, DME is dimethoxyethane, dppe is 1,2-bis(diphenylphosphino)ethane, THF is tetrahydrofuran, DCM is dichloromethane, S-Phos is dicyclohexyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine.

Synthesis of 5-chloro-2-(dibenzo[b,d]furan-4-yl)pyridine

Dibenzo[b,d]furan-4-ylboronic acid (9.5 g, 44.8 mmol), 2,5-dichloropyridine (7.0 g, 47.0 mmol), Pd(PPh 3 ) 4 (2.6 g, 2.2 mmol) and potassium carbonate (18.6 g, 134 mmol) were added to dimethoxyethane (75 mL) and water (75 mL). The reaction mixture was degassed with nitrogen before being heated to reflux overnight. EtOAc and water were added, the organic layer separated and the aqueous layer was extracted with 3×50 mL dichloromethane and dried over sodium sulfate. After removing the solvent under reduced pressure, the crude product was chromatographed on silica gel with dichloromethane to yield 11.7 g of crude product. The product was crystallized from hexane to give 9.5 g (76%) of 5-chloro-2-(dibenzo[b,d]furan-4-yl)pyridine as white needles. The product was confirmed by GC/MS.

Synthesis of 2-(dibenzo[b,d]furan-4-yl)-5-(prop-1-en-2-yl)pyridine

5-Chloro-2-(dibenzo[b,d]furan-4-yl)pyridine (9.5 g, 34.0 mmol), dicyclohexyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine (1.1 g, 2.7 mmol), and potassium phosphate tribasic monohydrate (23.5 g, 102 mmol) were added to toluene (200 mL) and water (20 mL) and the reaction mixture was degassed with nitrogen. Pd 2 (dba) 3 (0.622 g, 0.679 mmol) and 4,4,5,5-tetramethyl-2-(prop-1-en-2-yl)-1,3,2-dioxaborolane (7.7 mL, 40.8 mmol) were added and the reaction mixture was heated to reflux overnight. EtOAc and water were added, the organic layer separated and the aqueous layer was extracted with 3×50 mL dichloromethane and dried over sodium sulfate. After removing the solvent under reduced pressure, 12.7 g of amber oil was obtained. The crude material was chromatographed on silica with 9/1 (v/v) hexane/EtOAc to give 7.5 g (77%) of 2-(dibenzo[b,d]furan-4-yl)-5-(prop-1-en-2-yl)pyridine as a white solid. The product was confirmed by GC/MS and used without further purification.

Synthesis of 2-(dibenzo[b,d]furan-4-yl)-5-isopropylpyridine

2-(Dibenzo[b,d]furan-4-yl)-5-(prop-1-en-2-yl)pyridine (7.5 g, 26.3 mmol) was added to a hydrogenator bottle containing EtOH (150 mL). The reaction mixture was degassed by bubbling nitrogen for 10 min. Pd/C (0.28 g, 2.63 mmol) and Pt/C (0.26 g, 1.3 mmol) were added to the reaction mixture. The reaction mixture was placed on the Parr hydrogenator for 1 h. The reaction mixture was filtered on a tightly packed Celite® bed and washed with dichloromethane to yield 7.5 g (99%) of the desired product. The product was confirmed by GC/MS and NMR.

Synthesis of 5-chloro-2-(dibenzo[b,d]furan-4-yl)pyridine

Dibenzo[b,d]furan-4-ylboronic acid (25 g, 118 mmol), 2,4-dichloropyridine (19.2 g, 130 mmol), Pd(PPh 3 ) 4 (4.1 g, 3.5 mmol) and potassium carbonate (48.9 g, 354 mmol) were added to dimethoxyethane (200 mL) and water (200 mL). The reaction mixture was degassed with nitrogen before being heated to reflux overnight. EtOAc and water were added, the organic layer separated and the aqueous layer was extracted with 3×50 mL dichloromethane and dried over sodium sulfate. After removing the solvent under reduced pressure, the crude product was chromatographed on silica gel with dichloromethane to yield 33.4 g of crude product. The product was crystallized from hexane to give 27.0 g (82%) of 4-chloro-2-(dibenzo[b,d]furan-4-yl)pyridine as white needles. The product was confirmed by GC/MS and NMR.

Synthesis of 2-(dibenzo[b,d]furan-4-yl)-4-(prop-1-en-2-yl)pyridine

4-Chloro-2-(dibenzo[b,d]furan-4-yl)pyridine (24.0 g, 86.0 mmol), dicyclohexyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine (2.8 g, 6.9 mmol), and potassium phosphate tribasic monohydrate (59.3 g, 257 mmol) were added to toluene (400 mL) and water (40 mL) and the reaction mixture was degassed. Pd 2 (dba) 3 (1.6 g, 1.7 mmol) and 4,4,5,5-tetramethyl-2-(prop-1-en-2-yl)-1,3,2-dioxaborolane (19.4 mL, 103 mmol) were added and the reaction mixture was heated to reflux overnight. EtOAc and water were added, the organic layer separated and the aqueous layer was extracted with 3×50 mL dichloromethane and dried over sodium sulfate. After removing the solvent under reduced pressure, 33.0 g of amber oil was obtained. The crude material was chromatographed on silica with 9/1 (v/v) DCM/EtOAc to give 23.5 g (96%) of 2-(dibenzo[b,d]furan-4-yl)-4-(prop-1-en-2-yl)pyridine as a white solid. The product was confirmed by GC/MS and used without further purification.

›ETL · 3 of 9

Synthesis of 2-(dibenzo[b,d]furan-4-yl)-4-isopropylpyridine

2-(Dibenzo[b,d]furan-4-yl)-5-(prop-1-en-2-yl)pyridine (8.0 g, 28 mmol) was added to a hydrogenator bottle containing EtOH (150 mL). The reaction mixture was degassed by bubbling N 2 for 10 min. Pd/C (0.60 g, 5.6 mmol) and Pt/C (0.55 g, 2.8 mmol) were added to the reaction mixture. The reaction mixture was placed on the Parr hydrogenator for 1 h. The reaction mixture was filtered on a tightly packed Celite® bed and washed with dichloromethane. The crude product was chromatographed on silica gel with 9/1 (v/v) hexane/EtOAc to yield 7.2 g (96%) of 2-(dibenzo[b,d]furan-4-yl)-4-isopropylpyridine. The product was confirmed by GC/MS and NMR.

Synthesis of 5-bromo-2-(dibenzo[b,d]furan-4-yl)-4-methylpyridine

2,5-Dibromo-4-methylpyridine (30 g, 118 mmol), dibenzo[b,d]furan-4-ylboronic acid (25 g, 118 mmol), Pd(PPh 3 ) 4 (1.4 g, 1.18 mmol), and K 2 CO 3 (49 g, 354 mmol) were added to a flask with dimethoxyethane (450 mL) and water (100 mL) and degassed with nitrogen. The reaction mixture was heated to reflux for 15 h before cooling to room temperature. EtOAc and water were added, the organic layer separated and the aqueous layer was extracted with 3×50 mL dichloromethane and dried over sodium sulfate. After removing the solvent under reduced pressure, the crude product was chromatographed on silica gel with dichloromethane and 29.7 g of crude product was obtained. The product was crystallized from hexane to give 28.8 g (72%) of pure product. The product was confirmed by NMR and HPLC (99.3% pure)

Synthesis of 2-(dibenzo[b,d]furan-4-yl)-4,5-dimethylpyridine

5-Bromo-2-(dibenzo[b,d]furan-4-yl)-4-methylpyridine (28.7 g, 85 mmol), dicyclohexyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine (1.394 g, 3.39 mmol) and potassium phosphate monohydrate (58.6 g, 255 mmol) were added to toluene (500 mL) and water (50 mL) and degassed for 20 min. Trimethylboroxine (14.83 mL, 106 mmol) and Pd 2 (dba) 3 (0.777 g, 0.849 mmol) were added and the reaction mixture heated to reflux overnight. After cooling, the organic layer was separated and the aqueous layer extracted 3×50 mL with EtOAc, dried over sodium sulfate and evaporated. The crude product was chromatographed on silica gel with 8/2 (v/v) dichloromethane/EtOAc in hexane to give 19.2 g of an off-white solid, which was recrystallized from hexane to give 16.8 g (83%) of the product as white needles. The product was confirmed by NMR and HPLC (99.97% pure).

Synthesis of 2-(dibenzo[b,d]furan-4-yl)-5-isobutyl-4-methylpyridine

5-Bromo-2-(dibenzo[b,d]furan-4-yl)-4-methylpyridine (13.0 g, 38.3 mmol), isobutylboronic acid (11.7 g, 115 mmol), dicyclohexyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine (0.63 g, 1.53 mmol) and potassium phosphate monohydrate (22.1 g, 96 mmol) were mixed in water (10 mL) and toluene (210 mL). The system was degassed for 20 min. with nitrogen and Pd 2 (dba) 3 (0.35 g, 0.38 mmol) was then added and the system was refluxed overnight. After cooling to room temperature, the reaction mixture was filtered through a small plug of silica gel and eluted with dichloromethane. The filtrated was concentrated and then crystallized from hexane to give 2-(dibenzo[b,d]furan-4-yl)-5-isobutyl-4-methylpyridine (9.0 g, 74%).

Synthesis of 5-chloro-2-phenylpyridine

2,5-Dichloropyridine (30 g, 203 mmol), phenylboronic acid (24.72 g, 203 mmol) and potassium carbonate (84 g, 608 mmol) were added to dimethoxyethane (500 mL) and water (100 mL). The reaction mixture was degassed with nitrogen for 20 min, and Pd(PPh 3 ) 4 (2.3 g, 2.0 mmol) was added and reaction mixture was allowed to reflux for 18 h. The reaction was cooled to room temperature, the aqueous layer removed and dimethoxyethane was concentrated to dryness by rotary evaporation under vacuum. The residue was dissolved in DCM and passed through a silica gel plug, eluting with DCM. The solvent was removed and the crude product was chromatographed on silica with 40/60 (v/v) DCM/hexane to 50/50 (v/v) DCM/hexane to yield 28 g (73%) of the product as a white solid (HPLC purity: 99.7%).

Synthesis of 5-ethyl-2-phenylpyridine

5-Chloro-2-phenylpyridine (16 g, 84 mmol) and Ni(dppe)Cl 2 (0.891 g, 1.687 mmol) were added to 300 mL of THF and the reaction mixture was degassed with nitrogen for 20 min. before being cooled to 0° C. Ethylmagnesium bromide (169 mL, 169 mmol) was added dropwise over a period of 60 min. and the reaction mixture stirred for and additional 3 h at before warming to room temperature overnight. The reaction mixture was recooled to 0° C. and quenched with 250 mL of water, extracted with EtOAc and the organic layer dried over sodium sulfate and filtered. The crude material was chromatographed on silica with 95/5 hexane/EtOAc to give 2.9 g (19%) of 5-ethyl-2-phenylpyridine as a white solid.

Synthesis of 2-phenyl-5-(prop-1-en-2-yl)pyridine

To a 1 L round bottom flask was added 5-chloro-2-phenylpyridine (10.15 g, 53.5 mmol), dicyclohexyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine (1.8 g, 4.3 mmol), potassium phosphate tribasic monohydrate (37.0 g, 161 mmol) with toluene (200 mL) and water (20 mL). The reaction mixture was degassed with nitrogen for 20 mins. 4,4,5,5-tetramethyl-2-(prop-1-en-2-yl)-1,3,2-dioxaborolane (12.07 mL, 64.2 mmol) and Pd 2 (dba) 3 (0.980 g, 1.070 mmol) were added and the reaction mixture was refluxed for 18 h. The aqueous layer was removed and the organic layer was concentrated to dryness. The crude product was chromatographed on silica gel with 0-20% EtOAc in hexane to yield 11 g of the desired product (HPLC purity: 95%). The product was confirmed by GC/MS.

Synthesis of 2-phenyl-5-isopropylpyridine

2-Phenyl-5-(prop-1-en-2-yl)pyridine (11 g, 56.3 mmol) was added to a hydrogenator bottle containing EtOH (150 mL). The reaction mixture was degassed by bubbling N 2 for 10 min. Pd/C (0.60 g, 5.63 mmol) and Pt/C (0.55 g, 2.82 mmol) were added to the reaction mixture. The reaction mixture was placed on the Parr hydrogenator for 1.5 h. The reaction mixture was filtered on a tightly packed Celite® bed and washed with dichloromethane. The solvent was removed on rotoevaporator and GC/MS confirmed complete conversion. The crude product was adsorbed on Celite® for column chromatography. The crude product was chromatographed on silica gel with 10% EtOAc in hexane to yield 6 g (54%) of 2-phenyl-5-isopropylpyridine (HPLC purity: 100%). The product was confirmed by GC/MS.

›ETL · 4 of 9

Synthesis of 4-chloro-2-phenylpyridine

A 1 L round bottom flask was charged with 2,4-dichloropyridine (30 g, 203 mmol), phenylboronic acid (24.7 g, 203 mmol), potassium carbonate (84 g, 608 mmol), Pd(PPh 3 ) 4 (2.3 g, 2.0 mmol), dimethoxyethane (500 mL) and water (150 mL). The mixture was degassed and heated to reflux for 20 h. After cooling, the aqueous layer was extracted with EtOAc; the organic portion was combined and subjected to column chromatography (SiO 2 , 5% EtOAc in hexane to 10% EtOAc in hexane) to give 34 g (88%) of 4-chloro-2-phenylpyridine. The product was confirmed by GC/MS and NMR.

Synthesis of 2-phenyl-4-(prop-1-en-2-yl)pyridine

4-Chloro-2-phenylpyridine (14 g, 73.8 mmol) and potassium phosphate (51.0 g, 221 mmol) were dissolved in 300 mL of toluene and 30 mL of water. The reaction was purged with nitrogen for 20 minutes and then 4,4,5,5-tetramethyl-2-(prop-1-en-2-yl)-1,3,2-dioxaborolane (16.65 mL, 89 mmol), Pd 2 (dba) 3 (1.35 g, 1.48 mmol) and S-Phos (2.42 g, 5.91 mmol) were added. The reaction was brought to reflux for 18 h. After cooling, 100 mL of water was added, separated and the aqueous layer extracted twice with 100 mL of ethyl acetate. The organic layers were passed through a plug of silica gel, eluting with DCM. After evaporation of the solvent, the crude product was subjected to column chromatography (SiO 2 , 5% EtOAc in hexane to 10% EtOAc in hexane) to get 13.5 g (90%) of 2-phenyl-4-(prop-1-en-2-yl)pyridine.

Synthesis of 2-phenyl-4-isopropylpyridine

2-Phenyl-4-(prop-1-en-2-yl)pyridine (13.5 g, 69.1 mmol) was added to a hydrogenator bottle containing EtOH (150 mL). The reaction mixture was degassed by bubbling with nitrogen for 10 min. Pd/C (0.736 g, 6.9 mmol) and Pt/C (0.674 g, 3.5 mmol) was added to the reaction mixture. The reaction mixture was placed on the Parr hydrogenator for 2 h. The reaction mixture was filtered on a tightly packed Celite® bed and washed with dichloromethane. The solvent was removed on a rotary evaporator and GC/MS confirmed complete conversion. The crude product was adsorbed on Celite® for column chromatography. The crude product was chromatographed on silica gel with 10% EtOAc in hexane to yield 10 g (75%) of 2-phenyl-4-isopropylpyridine (HPLC purity: 99.8%). The product was confirmed by GC/MS.

Synthesis of 5-methyl-2-phenylpyridine

2-Bromo-5-methylpyridine (30 g, 174 mmol), phenylboronic acid (25.5 g, 209 mmol), dicyclohexyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine (2.86 g, 6.98 mmol) and potassium phosphate tribasic monohydrate (120 g, 523 mmol) were added to toluene (600 mL) and water (60 mL). The reaction mixture was degassed with nitrogen for 20 min. Pd 2 (dba) 3 (3.19 g, 3.49 mmol) was added and the reaction mixture was refluxed for 18 h. After cooling, the organic layer was separated and the aqueous layer extracted with 3×50 mL dichloromethane, dried over sodium sulfate and evaporated. The crude product was chromatographed on silica gel with 75/25 (v/v) hexane/EtOAc and then distilled on a Kugelrohr apparatus (150° C., 100 mbar) to give 26 g (88%) of 5-methyl-2-phenylpyridine as a white solid. The product was confirmed by NMR and GC/MS. HPLC purity: 99.2%.

Synthesis of 4-methyl-2-phenylpyridine

A 1 L round bottom flask was charged with 2-chloro-4-methylpyridine (25 g, 196 mmol), phenylboronic acid (23.9 g, 196 mmol), potassium carbonate (81 g, 588 mmol), Pd(PPh 3 ) 4 (2.3 g, 1.9 mmol), dimethoxyethane (500 mL) and water (150 mL). The reaction mixture was degassed with nitrogen and heated to reflux for 22 h. After cooling, the aqueous layer was extracted with EtOAc; the organic portion was combined and subjected to column chromatography (SiO 2 , 5% EtOAc in hexane to 10% EtOAc in hexane) to give 28 g (78%) of 4-methyl-2-phenylpyridine. The product was confirmed by NMR and GC/MS.

Synthesis of 4-ethyl-2-phenylpyridine

To 4-methyl-2-phenylpyridine (8 g, 47.3 mmol) in dry THF (150 mL) at −78° C. was added dropwise lithium diisopropylamide (LDA) (30.7 mL, 61.5 mmol). The dark solution was stirred for 3 h at −78° C. and then CH 3 I was added (4.1 mL, 66.2 mmol) dropwise. The reaction mixture was allowed to slowly warm to room temperature overnight. Ammonium chloride solution and EtOAc were added and the reaction transferred to a reparatory funnel. The layers were separated, washing the aqueous twice with EtOAc and combined organics once with water. After removal of the solvent, the crude product was chromatographed on silica gel with 9/1 (v/v) hexane/EtOAc to give 5.5 g (63.5%) of 4-ethyl-2-phenylpyridine. HPLC purity: 99.0%.

Synthesis of 4-methyl-2-phenylpyridine chloro-bridged dimer

To a 500 mL round-bottom flask was added 4-methyl-2-phenylpyridine (7 g, 41 mmol) and iridium(III) chloride hydrate (4.86 g, 13.79 mmol) with 2-ethoxyethanol (90 mL) and water (30 mL) under a nitrogen atmosphere. The resulting reaction mixture was refluxed at 130° C. for 18 h. The resulting precipitate was filtered and washed with methanol (3-4 times) and hexane (3-4 times). The product obtained was dried to give 7.5 g (90%) of the desired product. The product was used without further purification.

Synthesis of 5-methyl-2-phenylpyridine chloro-bridged dimer

To a 500 mL round bottom flask was added 5-methyl-2-phenylpyridine (12 g, 70.9 mmol) and iridium(III) chloride hydrate (7.1 g, 20.3 mmol) with 2-ethoxyethanol (100 mL) and water (33.3 mL) under a nitrogen atmosphere. The resulting reaction mixture was refluxed at 130° C. for 18 h. The resulting precipitate was filtered and washed with methanol (3-4 times) and hexane (3-4 times). The product obtained was dried to give 11.0 g (96%) of the desired product. The product was used without further purification.

Synthesis of 2-phenyl-5-isopropylpyridine chloro-bridged dimer

To a 500 mL round-bottom flask was added 5-isopropyl-2-phenylpyridine (6.0 g, 30.4 mmol) and iridium(III) chloride hydrate (3.6 g, 10.1 mmol) with 2-ethoxyethanol (100 mL) and water (33.3 mL) under a nitrogen atmosphere. The resulting reaction mixture was refluxed at 130° C. for 18 h. The resulting precipitate was filtered and washed with methanol (3-4 times) and hexane (3-4 times). The product obtained was dried to give 7 g (100%) of the desired product. The product was used without further purification.

›ETL · 5 of 9

Synthesis of 2-phenyl-4-isopropylpyridine chloro-bridged dimmer

To a 500 mL round-bottom flask was added 4-isopropyl-2-phenylpyridine (8.0 g, 40.6 mmol) and iridium(III) chloride hydrate (7.4 g, 20.3 mmol) with 2-ethoxyethanol (90 mL) and water (30 mL) under a nitrogen atmosphere. The resulting reaction mixture was refluxed at 130° C. for 18 h. The resulting precipitate was filtered and washed with methanol (3-4 times) and hexane (3-4 times). The product obtained was dried to give 6.1 g (95%) of the desired product. The product was used without further purification.

Synthesis of 4-ethyl-2-phenylpyridine chloro-bridged dimmer

To a 500 mL round-bottom flask was added 4-isopropyl-2-phenylpyridine (5.5 g, 30.0 mmol) and iridium(III) chloride hydrate (5.8 g, 16.5 mmol) with 2-ethoxyethanol (90 mL) and water (30 mL) under a nitrogen atmosphere. The resulting reaction mixture was refluxed at 130° C. for 18 h. The resulting precipitate was filtered and washed with methanol (3-4 times) and hexane (3-4 times). The product obtained was dried to give 6.5 g (72%) of the desired product. The product was used without further purification.

Synthesis of 5-ethyl-2-phenylpyridine chloro-bridged dimer

To a 500 mL round bottom flask was added 5-ethyl-2-phenylpyridine (2.9 g, 15.7 mmol) and iridium(III) chloride hydrate (1.8 g, 5.2 mmol) with 2-ethoxyethanol (60 mL) and water (20 mL) under a nitrogen atmosphere. The reaction mixture was refluxed at 130° C. for 18 h. The resulting precipitate was filtered and washed with methanol (3-4 times) and hexane (3-4 times). The product obtained was dried to give 2.45 g (89.3%) of the desired product. The product was used without further purification.

Synthesis of 5-methyl-2-phenylpyridine iridium trifluoromethanesulfonate salt

The iridium dimer (11 g, 9.8 mmol) was suspended in 600 mL of dichloromethane. In a separate flask, silver(I) trifluoromethanesulfonate (5.3 g, 20.5 mmol) was dissolved in MeOH (300 mL) and added slowly to the dichloromethane solution with continuous stirring at room temperature. The reaction mixture was stirred overnight in the dark. The reaction mixture was filtered through a tightly packed Celite® bed and the solvent was removed under vacuum to give 15 g (100%) of product as a brownish green solid. The product was used without further purification.

Synthesis of 4-methyl-2-phenylpyridine iridium trifluoromethanesulfonate salt

The iridium dimer (7.5 g, 6.6 mmol) was dissolved in 600 mL of dichloromethane. In a separate flask, silver(I) trifluoromethanesulfonate (3.5 g, 13.8 mmol) was dissolved in MeOH (300 mL) and added slowly to the dichloromethane solution with continuous stirring at room temperature. The reaction mixture was stirred overnight in the dark. The reaction mixture was filtered through a tightly packed Celite® bed and the solvent was removed under vacuum to give 10 g (100%) of product as a brownish green solid. The product was used without further purification.

Synthesis of 2-phenyl-5-isopropylpyridine iridium trifluoromethanesulfonate salt

The iridium dimer (5.3 g, 4.3 mmol) was dissolved in 500 mL of dichloromethane. In a separate flask, silver(I) trifluoromethanesulfonate (2.3 g, 8.9 mmol) was dissolved in MeOH (250 mL) and added slowly to the dichloromethane solution with continuous stirring at room temperature. The reaction mixture was stirred overnight in the dark. The reaction mixture was filtered through a tightly packed Celite® bed and the solvent was removed under vacuum to give 6.9 g (100%) of product as a brownish solid. The product was used without further purification.

Synthesis of 2-phenyl-4-isopropylpyridine iridium trifluoromethanesulfonate salt

The iridium dimer (6.2 g, 4.94 mmol) was dissolved in 500 mL of dichloromethane. In a separate flask, silver(I) trifluoromethanesulfonate (2.7 g, 10.4 mmol) was dissolved in MeOH (250 mL) and added slowly to the dichloromethane solution with continuous stirring at room temperature. The reaction mixture was stirred overnight in the dark. The reaction mixture was filtered through a tightly packed Celite® bed and the solvent was removed under vacuum to give 7.8 g (100%) of product as a brownish green solid. The product was used without further purification.

Synthesis of 4-ethyl-2-phenylpyridine iridium trifluoromethanesulfonate salt

The iridium dimer (6.8 g, 5.7 mmol) was dissolved in 500 mL of dichloromethane. In a separate flask, silver(I) trifluoromethanesulfonate (3.2 g, 12.5 mmol) was dissolved in MeOH (250 mL) and added slowly to the dichloromethane solution with continuous stirring at room temperature. The reaction mixture was stirred overnight in the dark. The reaction mixture was filtered through a tightly packed Celite® bed and the solvent was removed under vacuum to give 5.5 g (63%) of product as a brownish green solid. The product was used without further purification.

Synthesis of 5-ethyl-2-phenylpyridine iridium trifluoromethanesulfonate salt

The iridium dimer (2.8 g, 2.4 mmol) was suspended in 500 mL of dichloromethane. In a separate flask, silver(I) trifluoromethanesulfonate (1.3 g, 4.91 mmol) was dissolved in MeOH (250 mL) and added slowly to the dichloromethane solution with continuous stirring at room temperature. The reaction mixture was stirred overnight in the dark. The reaction mixture was filtered through a tightly packed Celite® bed and the solvent was removed under vacuum to give 3.6 g (100%) of product as a brownish green solid. The product was used without further purification.

Synthesis of Compound 53

A mixture of the appropriate iridium trifluoromethanesulfonate complex (3.5 g, 4.9 mmol) and 2-(dibenzo[b,d]furan-4-yl)-5-isopropylpyridine (3.5 g, 12.18 mmol) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane to yield 1.3 g (33%) of Compound 53 as a yellow solid. The product was confirmed by HPLC (99.5% pure) and LC/MS.

›ETL · 6 of 9

Synthesis of Compound 157

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.5 g, 3.50 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4,5-dimethylpyridine (2.5 g, 9.15 mmol)) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was refluxed for 24 h. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a fit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The solvent was removed to half the volume and the product precipitated by addition of isopropanol and removing dichloromethane under reduced pressure. The filtered material was washed with isopropanol and hexane to yield a mixture of fac- and mer-isomers by LC/MS. The mixture was isomerized to the fac-isomer in a Rayonet at 350 nm in DMSO. The crude product was chromatographed on silica gel with 1/1 dichloromethane/hexane to yield 1.4 g (52%) of Compound 157 as a yellow solid. The product was confirmed by HPLC (98.7% pure) and LC/MS.

Synthesis of Compound 158

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.5 g, 3.37 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4,5-dimethylpyridine (2.5 g, 9.15 mmol) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The solvent was removed to half the volume and the product precipitated by addition of isopropanol and removing dichloromethane under reduced pressure. The filtered material was washed with isopropanol and hexane and dried to yield 2.7 g (100%) of Compound 158 as a yellow solid. The product was confirmed by HPLC (99.4% pure) and LC/MS.

Synthesis of Compound 159

A mixture of the appropriate iridium trifluoromethanesulfonate complex (3.0 g, 4.04 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4,5-dimethylpyridine (3.0 g, 10.98 mmol) in EtOH (30 mL) and MeOH (30 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The solubility of the desired product was very poor. Large amount of solvent was used to elute the product. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane and later 4/1 dichloromethane/hexane to yield 0.3 g of the product as a yellow solid. The product was confirmed by HPLC (99.9% pure) and LC/MS.

Synthesis of Compound 165

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.5 g, 3.25 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4,5-dimethylpyridine (2.5 g, 9.15 mmol) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The solvent was removed to half the volume and the product precipitated by addition of isopropanol and removing dichloromethane under reduced pressure. The filtered material was washed with isopropanol and hexane and dried. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane to yield 1.2 g (43%) of Compound 165 as a yellow solid. The product was confirmed by HPLC (99.4% pure) and LC/MS.

Synthesis of Compound 174

A mixture of the appropriate iridium trifluoromethanesulfonate complex (3.6 g, 4.68 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4,5-dimethylpyridine (3.6 g, 13.17 mmol) in EtOH (50 mL) and MeOH (50 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a fit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane to yield 0.8 g of product as a yellow solid was confirmed by HPLC (98.6% pure) and LC/MS.

Synthesis of Compound 175

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.5 g, 3.25 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4,5-dimethylpyridine (2.66 g, 9.74 mmol) in EtOH (30 mL) and MeOH (30 mL) was refluxed for 20 h under nitrogen atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 2/3 (v/v) THF/hexane to yield 0.8 g of product by HPLC. The product was recrystallized by slow evaporation of DCM from a 1/3 DCM/hexane solution to yield 0.6 g (22%) as a yellow crystalline solid. The product was confirmed by HPLC (99.4% pure) and LC/MS.

Synthesis of Compound 184

A mixture of the appropriate iridium trifluoromethanesulfonate complex (3.0 g, 3.76 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4,5-dimethylpyridine (3.0 g, 10.98 mmol) in EtOH (30 mL) and MeOH (30 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a fit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane to yield 2.1 g (65%) of product as a yellow solid. The product was confirmed by HPLC (99.8% pure) and LC/MS.

›ETL · 7 of 9

Synthesis of Compound 185

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.8 g, 3.51 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4,5-dimethylpyridine (2.88.0 g, 10.53 mmol) in EtOH (30 mL) and MeOH (30 mL) was refluxed for 20 h under N 2 atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 2/3 (v/v) dichloromethane/hexane to yield 2.1 g (69%) of product as a yellow solid. The product was confirmed by HPLC (99.9% pure) and LC/MS.

Synthesis of Compound 314

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.5 g, 3.37 mmol) and 2-(dibenzo[b,d]furan-4-yl)-5-isobutyl-4-methylpyridine (2.5 g, 7.93 mmol) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a fit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The solvent was removed to half the volume and the product precipitated by addition of isopropanol and removing dichloromethane under reduced pressure. The filtered material was washed with isopropanol and hexane and dried to yield 3.0 g (100%) of Compound 314 as a yellow solid. The product was confirmed by HPLC (99.6% pure) and LC/MS.

Synthesis of Compound 321

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.2 g, 2.86 mmol) and 2-(dibenzo[b,d]furan-4-yl)-5-isobutyl-4-methylpyridine (2.2 g, 6.98 mmol) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a fit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The solvent was removed to half the volume and the product precipitated by addition of isopropanol and removing dichloromethane under reduced pressure. The filtered material was washed with isopropanol and hexane. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane to yield 1.6 g (50%) of Compound 321 as a yellow solid. The product was confirmed by HPLC (99.0% pure) and LC/MS.

Synthesis of Compound 625

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.2 g, 3.08 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4-isopropylpyridine (2.2 g, 7.66 mmol) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The solvent was removed to half the volume and the product precipitated by addition of isopropanol and removing dichloromethane under reduced pressure. The filtered material was washed with isopropanol and hexane and dried to yield 1.7 g (67%) of Compound 625 as a yellow solid. The product was confirmed by HPLC (99.8% pure) and LC/MS.

Synthesis of Compound 626

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.5 g, 3.37 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4-isopropylpyridine (2.5 g, 8.70 mmol) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The solvent was removed to half the volume and the product precipitated by addition of isopropanol and removing dichloromethane under reduced pressure. The filtered material was washed with isopropanol and hexane and dried. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane to yield 2.5 g (89%) of Compound 626 as a yellow solid. The product was confirmed by HPLC (99.4% pure) and LC/MS.

Synthesis of Compound 627

A mixture of the appropriate iridium trifluoromethanesulfonate complex (3.0 g, 4.0 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4-isopropylpyridine (3.0 g, 10.4 mmol in EtOH (30 mL) and MeOH (30 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane to yield 2.0 g (60%) of Compound 627 as a yellow solid. The product was confirmed by HPLC (99.9% pure) and LC/MS.

Synthesis of Compound 628

A mixture of the appropriate iridium trifluoromethanesulfonate complex (3.0 g, 4.0 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4-isopropylpyridine (3.0 g, 10.5 mmol) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 24 h under nitrogen atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 2/3 (v/v) dichloromethane/hexane to yield 2.1 g (64%) of product as a yellow solid. The product was confirmed by HPLC (99.95% pure) and LC/MS.

›ETL · 8 of 9

Synthesis of Compound 633

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.5 g, 3.25 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4-isopropylpyridine (2.5 g, 8.70 mmol) in EtOH (25 mL) and MeOH (25 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The solvent was removed to half the volume and the product precipitated by addition of isopropanol and removing dichloromethane under reduced pressure. The filtered material was washed with isopropanol and hexane and dried. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane to yield 1.6 g (59%) of Compound 633 as a yellow solid. The product was confirmed by HPLC (99.7% pure) and LC/MS.

Synthesis of Compound 643

A mixture of the appropriate iridium trifluoromethanesulfonate complex (2.4 g, 3.12 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4-ethylpyridine (2.69 g, 9.35 mmol) in EtOH (30 mL) and MeOH (30 mL) was refluxed for 20 h under nitrogen atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 2/3 (v/v) dichloromethane/hexane to yield 1.3 g (50%) of product as a yellow solid. The product was confirmed by HPLC (100% pure) and LC/MS.

Synthesis of Compound 652

A mixture of the appropriate iridium trifluoromethanesulfonate complex (3.1 g, 3.9 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4-isopropylpyridine (3.1 g, 10.9 mmol) in EtOH (30 mL) and MeOH (30 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 1/1 (v/v) dichloromethane/hexane to yield 2.1 g (62%) of Compound 652 as a yellow solid. The product was confirmed by HPLC (99.9% pure) and LC/MS

Synthesis of Compound 653

A mixture of iridium trifluoromethanesulfonate complex (2.4 g, 3.01 mmol) and 2-(dibenzo[b,d]furan-4-yl)4isopropylpyridine (3.0 g, 9.02 mmol) in EtOH (30 mL) and MeOH (30 mL) was refluxed for 20 h under nitrogen atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with 2/3 (v/v) dichloromethane/hexane to yield 0.96 g (45%) of product as a yellow solid. The product was confirmed by HPLC (99.8% pure) and LC/MS.

Synthesis of 2-(dibenzo[b,d]furan-4-yl)-4-ethyl-d 3 -pyridine

To 2-(dibenzo[b,d]furan-4-yl)-4-methylpyridine (15.3 g, 59.0 mmol) in dry THF (250 mL) at −78° C. was added dropwise lithium diisopropylamide (35.4 mL, 70.8 mmol). The dark solution was stirred for 2 h at −78° C. and then CD 3 I was added (4.41 mL, 70.8 mmol) dropwise. The reaction mixture was allowed to slowly warm to RT overnight. Ammonium chloride solution and EtOAc were added and the reaction transferred separatory funnel. The layers were separated, washing the aqueous twice with EtOAc and combined organics once with water. After removal of the solvent, the crude product was chromatographed on silica gel with 8/2 (v/v) hexane/EtOAc and then 7/3 hexane/EtOAc to give 14.5 g of product as a pale yellow solid. Recrystallization from hexane gave 12.9 g (79%) of 2-(dibenzo[b,d]furan-4-yl)-4-ethyl-d 3 -pyridine. HPLC purity: 99.4%.

Synthesis of 2-(dibenzo[b,d]furan-4-yl)-4-isopropyl-d 6 -pyridine

2-(Dibenzo[b,d]furan-4-yl)-4-ethyl-d 3 -pyridine was dissolved in dry THF (100 mL) and cooled to −78° C. Lithium diisopropylamide (19.0 mL, 38.0 mmol) was added dropwise and the reaction mixture stirred for 2 h at −78° C. CD 3 I was added dropwise and the reaction mixture was allowed to slowly warm to room temperature overnight. The reaction was quenched with MeOH, NH 4 Cl (aq.) and EtOAc were added and the bipasic mixture transferred to a separatory funnel, The layers were separated, washing the aqueous layer twice with EtOAc and the combined organics with water. After removal of the solvent, the crude product was chromatographed on silica gel with 8/2 (v/v) hexane/EtOAc to give 6.4 g (86%) of 2-(dibenzo[b,d]furan-4-yl)-4-isopropyl-d 6 -pyridine. HPLC purity: 99.2%.

Synthesis of Compound 1145

A mixture of the appropriate iridium trifluoromethanesulfonate complex (3.5 g, 4.9 mmol) and 2-(dibenzo[b,d]furan-4-yl)-4-d 3 -ethylpyridine (3.5 g, 12.7 mmol) in EtOH (30 mL) and MeOH (30 mL) was refluxed for 20 h under inert atmosphere. The reaction mixture was cooled to room temperature, diluted with ethanol, celite was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a frit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The Celite®/silica plug was then washed with dichloromethane to elute the product. The crude product was chromatographed on silica gel with dichloromethane to yield 1.8 g (47%) of Compound 1145 as a yellow solid. The product was confirmed by HPLC (98.7% pure) and LC/MS.

›ETL · 9 of 9

Synthesis of Compound 1146

2-(Dibenzo[b,d]furan-4-yl)-4-isopropyl-d 6 -pyridine and the appropriate iridium trifluoromethanesulfonate complex were combined in ethanol (25 mL) and methanol (25 mL) and heated to reflux for 16 h. The reaction mixture was cooled to room temperature, diluted with ethanol, Celite® was added and the mixture stirred for 10 min. The mixture was filtered on a small silica gel plug on a fit and washed with ethanol (3-4 times) and with hexane (3-4 times). The filtrate was discarded. The celite/silica plug was then washed with dichloromethane to dissolve the product. The crude product was chromatographed on silica gel with 50-70% dichloromethane in hexane to and then sublimed to yield 1.7 g (43%) of Compound 1146 as a yellow solid. The product was confirmed by HPLC (99.5% pure) and LC/MS.

It is understood that the various embodiments described herein are by way of example only, and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting.

›Tables in the description — 3
TABLE 1
Compound #R 1R 2R 3R 4R 5R 6
1.HEthylHHHH
2.HEthylMethylHHH
3.HEthylHMethylHH
4.HEthylHHMethylH
5.HEthylHHHMethyl
6.HEthylMethylMethylHH
7.HEthylMethylHMethylH
8.HEthylMethylHHMethyl
9.HEthylHMethylMethylH
10.HEthylHMethylHMethyl
11.HEthylHHMethylMethyl
12.HEthylMethylMethylMethylH
13.HEthylMethylMethylHMethyl
14.HEthylMethylHMethylMethyl
15.HEthylHMethylMethylMethyl
16.HEthylMethylMethylMethylMethyl
17.HEthylEthylHHH
18.HEthylHEthylHH
19.HEthylHHEthylH
20.HEthylHHHEthyl
21.HEthylMethylEthylHH
22.HEthylMethylHEthylH
23.HEthylMethylHHEthyl
24.HEthylHEthylMethylH
25.HEthylHEthylEthylH
26.HEthylHMethylEthylH
27.HEthylIsopropylHHH
28.HEthylHIsopropylHH
29.HEthylHHIsopropylH
30.HEthylHHHIsopropyl
31.HEthylMethylIsopropylHH
32.HEthylMethylHIsopropylH
33.HEthylMethylHHIsopropyl
34.HEthylHIsopropylMethylH
35.HEthylHIsopropylIsopropylH
36.HEthylHMethylIsopropylH
37.HEthylHIsopropylEthylH
38.HEthylHEthylIsopropylH
39.HEthylIsobutylHHH
40.HEthylHIsobutylHH
41.HEthylHHIsobutylH
42.HEthylHHHIsobutyl
43.HEthylMethylIsobutylHH
44.HEthylMethylHIsobutylH
45.HEthylMethylHHIsobutyl
46.HEthylHIsobutylMethylH
47.HEthylHIsobutylIsobutylH
48.HEthylHMethylIsobutylH
49.HEthylHIsobutylEthylH
50.HEthylHEthylIsobutylH
51.HEthylHIsobutylIsopropylH
52.HEthylHIsopropylIsobutylH
53.HIsopropylHHHH
54.HIsopropylMethylHHH
55.HIsopropylHMethylHH
56.HIsopropylHHMethylH
57.HIsopropylHHHMethyl
58.HIsopropylMethylMethylHH
59.HIsopropylMethylHMethylH
60.HIsopropylMethylHHMethyl
61.HIsopropylHMethylMethylH
62.HIsopropylHMethylHMethyl
63.HIsopropylHHMethylMethyl
64.HIsopropylMethylMethylMethylH
65.HIsopropylMethylMethylHMethyl
66.HIsopropylMethylHMethylMethyl
67.HIsopropylHMethylMethylMethyl
68.HIsopropylMethylMethylMethylMethyl
69.HIsopropylEthylHHH
70.HIsopropylHEthylHH
71.HIsopropylHHEthylH
72.HIsopropylHHHEthyl
73.HIsopropylMethylEthylHH
74.HIsopropylMethylHEthylH
75.HIsopropylMethylHHEthyl
76.HIsopropylHEthylMethylH
77.HIsopropylHEthylEthylH
78.HIsopropylHMethylEthylH
79.HIsopropylIsopropylHHH
80.HIsopropylHIsopropylHH
81.HIsopropylHHIsopropylH
82.HIsopropylHHHIsopropyl
83.HIsopropylMethylIsopropylHH
84.HIsopropylMethylHIsopropylH
85.HIsopropylMethylHHIsopropyl
86.HIsopropylHIsopropylMethylH
87.HIsopropylHIsopropylIsopropylH
88.HIsopropylHMethylIsopropylH
89.HIsopropylHIsopropylEthylH
90.HIsopropylHEthylIsopropylH
91.HIsopropylIsobutylHHH
92.HIsopropylHIsobutylHH
93.HIsopropylHHIsobutylH
94.HIsopropylHHHIsobutyl
95.HIsopropylMethylIsobutylHH
96.HIsopropylMethylHIsobutylH
97.HIsopropylMethylHHIsobutyl
98.HIsopropylHIsobutylMethylH
99.HIsopropylHIsobutylIsobutylH
100.HIsopropylHMethylIsobutylH
101.HIsopropylHIsobutylEthylH
102.HIsopropylHEthylIsobutylH
103.HIsopropylHIsobutylIsopropylH
104.HIsopropylHIsopropylIsobutylH
105.HIsobutylHHHH
106.HIsobutylMethylHHH
107.HIsobutylHMethylHH
108.HIsobutylHHMethylH
109.HIsobutylHHHMethyl
110.HIsobutylMethylMethylHH
111.HIsobutylMethylHMethylH
112.HIsobutylMethylHHMethyl
113.HIsobutylHMethylMethylH
114.HIsobutylHMethylHMethyl
115.HIsobutylHHMethylMethyl
116.HIsobutylMethylMethylMethylH
117.HIsobutylMethylMethylHMethyl
118.HIsobutylMethylHMethylMethyl
119.HIsobutylHMethylMethylMethyl
120.HIsobutylMethylMethylMethylMethyl
121.HIsobutylEthylHHH
122.HIsobutylHEthylHH
123.HIsobutylHHEthylH
124.HIsobutylHHHEthyl
125.HIsobutylMethylEthylHH
126.HIsobutylMethylHEthylH
127.HIsobutylMethylHHEthyl
128.HIsobutylHEthylMethylH
129.HIsobutylHEthylEthylH
130.HIsobutylHMethylEthylH
131.HIsobutylIsopropylHHH
132.HIsobutylHIsopropylHH
133.HIsobutylHHIsopropylH
134.HIsobutylHHHIsopropyl
135.HIsobutylMethylIsopropylHH
136.HIsobutylMethylHIsopropylH
137.HIsobutylMethylHHIsopropyl
138.HIsobutylHIsopropylMethylH
139.HIsobutylHIsopropylIsopropylH
140.HIsobutylHMethylIsopropylH
141.HIsobutylHIsopropylEthylH
142.HIsobutylHEthylIsopropylH
143.HIsobutylIsobutylHHH
144.HIsobutylHIsobutylHH
145.HIsobutylHHIsobutylH
146.HIsobutylHHHIsobutyl
147.HIsobutylMethylIsobutylHH
148.HIsobutylMethylHIsobutylH
149.HIsobutylMethylHHIsobutyl
150.HIsobutylHIsobutylMethylH
151.HIsobutylHIsobutylIsobutylH
152.HIsobutylHMethylIsobutylH
153.HIsobutylHIsobutylEthylH
154.HIsobutylHEthylIsobutylH
155.HIsobutylHIsobutylIsopropylH
156.HIsobutylHIsopropylIsobutylH
157.MethylMethylHHHH
158.MethylMethylMethylHHH
159.MethylMethylHMethylHH
160.MethylMethylHHMethylH
161.MethylMethylHHHMethyl
162.MethylMethylMethylMethylHH
163.MethylMethylMethylHMethylH
164.MethylMethylMethylHHMethyl
165.MethylMethylHMethylMethylH
166.MethylMethylHMethylHMethyl
167.MethylMethylHHMethylMethyl
168.MethylMethylMethylMethylMethylH
169.MethylMethylMethylMethylHMethyl
170.MethylMethylMethylHMethylMethyl
171.MethylMethylHMethylMethylMethyl
172.MethylMethylMethylMethylMethylMethyl
173.MethylMethylEthylHHH
174.MethylMethylHEthylHH
175.MethylMethylHHEthylH
176.MethylMethylHHHEthyl
177.MethylMethylMethylEthylHH
178.MethylMethylMethylHEthylH
179.MethylMethylMethylHHEthyl
180.MethylMethylHEthylMethylH
181.MethylMethylHEthylEthylH
182.MethylMethylHMethylEthylH
183.MethylMethylIsopropylHHH
184.MethylMethylHIsopropylHH
185.MethylMethylHHIsopropylH
186.MethylMethylHHHIsopropyl
187.MethylMethylMethylIsopropylHH
188.MethylMethylMethylHIsopropylH
189.MethylMethylMethylHHIsopropyl
190.MethylMethylHIsopropylMethylH
191.MethylMethylHIsopropylIsopropylH
192.MethylMethylHMethylIsopropylH
193.MethylMethylHIsopropylEthylH
194.MethylMethylHEthylIsopropylH
195.MethylMethylIsobutylHHH
196.MethylMethylHIsobutylHH
197.MethylMethylHHIsobutylH
198.MethylMethylHHHIsobutyl
199.MethylMethylMethylIsobutylHH
200.MethylMethylMethylHIsobutylH
201.MethylMethylMethylHHIsobutyl
202.MethylMethylHIsobutylMethylH
203.MethylMethylHIsobutylIsobutylH
204.MethylMethylHMethylIsobutylH
205.MethylMethylHIsobutylEthylH
206.MethylMethylHEthylIsobutylH
207.MethylMethylHIsobutylIsopropylH
208.MethylMethylHIsopropylIsobutylH
209.MethylEthylHHHH
210.MethylEthylMethylHHH
211.MethylEthylHMethylHH
212.MethylEthylHHMethylH
213.MethylEthylHHHMethyl
214.MethylEthylMethylMethylHH
215.MethylEthylMethylHMethylH
216.MethylEthylMethylHHMethyl
217.MethylEthylHMethylMethylH
218.MethylEthylHMethylHMethyl
219.MethylEthylHHMethylMethyl
220.MethylEthylMethylMethylMethylH
221.MethylEthylMethylMethylHMethyl
222.MethylEthylMethylHMethylMethyl
223.MethylEthylHMethylMethylMethyl
224.MethylEthylMethylMethylMethylMethyl
225.MethylEthylEthylHHH
226.MethylEthylHEthylHH
227.MethylEthylHHEthylH
228.MethylEthylHHHEthyl
229.MethylEthylMethylEthylHH
230.MethylEthylMethylHEthylH
231.MethylEthylMethylHHEthyl
232.MethylEthylHEthylMethylH
233.MethylEthylHEthylEthylH
234.MethylEthylHMethylEthylH
235.MethylEthylIsopropylHHH
236.MethylEthylHIsopropylHH
237.MethylEthylHHIsopropylH
238.MethylEthylHHHIsopropyl
239.MethylEthylMethylIsopropylHH
240.MethylEthylMethylHIsopropylH
241.MethylEthylMethylHHIsopropyl
242.MethylEthylHIsopropylMethylH
243.MethylEthylHIsopropylIsopropylH
244.MethylEthylHMethylIsopropylH
245.MethylEthylHIsopropylEthylH
246.MethylEthylHEthylIsopropylH
247.MethylEthylIsobutylHHH
248.MethylEthylHIsobutylHH
249.MethylEthylHHIsobutylH
250.MethylEthylHHHIsobutyl
251.MethylEthylMethylIsobutylHH
252.MethylEthylMethylHIsobutylH
253.MethylEthylMethylHHIsobutyl
254.MethylEthylHIsobutylMethylH
255.MethylEthylHIsobutylIsobutylH
256.MethylEthylHMethylIsobutylH
257.MethylEthylHIsobutylEthylH
258.MethylEthylHEthylIsobutylH
259.MethylEthylHIsobutylIsopropylH
260.MethylEthylHIsopropylIsobutylH
261.MethylIsopropylHHHH
262.MethylIsopropylMethylHHH
263.MethylIsopropylHMethylHH
264.MethylIsopropylHHMethylH
265.MethylIsopropylHHHMethyl
266.MethylIsopropylMethylMethylHH
267.MethylIsopropylMethylHMethylH
268.MethylIsopropylMethylHHMethyl
269.MethylIsopropylHMethylMethylH
270.MethylIsopropylHMethylHMethyl
271.MethylIsopropylHHMethylMethyl
272.MethylIsopropylMethylMethylMethylH
273.MethylIsopropylMethylMethylHMethyl
274.MethylIsopropylMethylHMethylMethyl
275.MethylIsopropylHMethylMethylMethyl
276.MethylIsopropylMethylMethylMethylMethyl
277.MethylIsopropylEthylHHH
278.MethylIsopropylHEthylHH
279.MethylIsopropylHHEthylH
280.MethylIsopropylHHHEthyl
281.MethylIsopropylMethylEthylHH
282.MethylIsopropylMethylHEthylH
283.MethylIsopropylMethylHHEthyl
284.MethylIsopropylHEthylMethylH
285.MethylIsopropylHEthylEthylH
286.MethylIsopropylHMethylEthylH
287.MethylIsopropylIsopropylHHH
288.MethylIsopropylHIsopropylHH
289.MethylIsopropylHHIsopropylH
290.MethylIsopropylHHHIsopropyl
291.MethylIsopropylMethylIsopropylHH
292.MethylIsopropylMethylHIsopropylH
293.MethylIsopropylMethylHHIsopropyl
294.MethylIsopropylHIsopropylMethylH
295.MethylIsopropylHIsopropylIsopropylH
296.MethylIsopropylHMethylIsopropylH
297.MethylIsopropylHIsopropylEthylH
298.MethylIsopropylHEthylIsopropylH
299.MethylIsopropylIsobutylHHH
300.MethylIsopropylHIsobutylHH
301.MethylIsopropylHHIsobutylH
302.MethylIsopropylHHHIsobutyl
303.MethylIsopropylMethylIsobutylHH
304.MethylIsopropylMethylHIsobutylH
305.MethylIsopropylMethylHHIsobutyl
306.MethylIsopropylHIsobutylMethylH
307.MethylIsopropylHIsobutylIsobutylH
308.MethylIsopropylHMethylIsobutylH
309.MethylIsopropylHIsobutylEthylH
310.MethylIsopropylHEthylIsobutylH
311.MethylIsopropylHIsobutylIsopropylH
312.MethylIsopropylHIsopropylIsobutylH
313.MethylIsobutylHHHH
314.MethylIsobutylMethylHHH
315.MethylIsobutylHMethylHH
316.MethylIsobutylHHMethylH
317.MethylIsobutylHHHMethyl
318.MethylIsobutylMethylMethylHH
319.MethylIsobutylMethylHMethylH
320.MethylIsobutylMethylHHMethyl
321.MethylIsobutylHMethylMethylH
322.MethylIsobutylHMethylHMethyl
323.MethylIsobutylHHMethylMethyl
324.MethylIsobutylMethylMethylMethylH
325.MethylIsobutylMethylMethylHMethyl
326.MethylIsobutylMethylHMethylMethyl
327.MethylIsobutylHMethylMethylMethyl
328.MethylIsobutylMethylMethylMethylMethyl
329.MethylIsobutylEthylHHH
330.MethylIsobutylHEthylHH
331.MethylIsobutylHHEthylH
332.MethylIsobutylHHHEthyl
333.MethylIsobutylMethylEthylHH
334.MethylIsobutylMethylHEthylH
335.MethylIsobutylMethylHHEthyl
336.MethylIsobutylHEthylMethylH
337.MethylIsobutylHEthylEthylH
338.MethylIsobutylHMethylEthylH
339.MethylIsobutylIsopropylHHH
340.MethylIsobutylHIsopropylHH
341.MethylIsobutylHHIsopropylH
342.MethylIsobutylHHHIsopropyl
343.MethylIsobutylMethylIsopropylHH
344.MethylIsobutylMethylHIsopropylH
345.MethylIsobutylMethylHHIsopropyl
346.MethylIsobutylHIsopropylMethylH
347.MethylIsobutylHIsopropylIsopropylH
348.MethylIsobutylHMethylIsopropylH
349.MethylIsobutylHIsopropylEthylH
350.MethylIsobutylHEthylIsopropylH
351.MethylIsobutylIsobutylHHH
352.MethylIsobutylHIsobutylHH
353.MethylIsobutylHHIsobutylH
354.MethylIsobutylHHHIsobutyl
355.MethylIsobutylMethylIsobutylHH
356.MethylIsobutylMethylHIsobutylH
357.MethylIsobutylMethylHHIsobutyl
358.MethylIsobutylHIsobutylMethylH
359.MethylIsobutylHIsobutylIsobutylH
360.MethylIsobutylHMethylIsobutylH
361.MethylIsobutylHIsobutylEthylH
362.MethylIsobutylHEthylIsobutylH
363.MethylIsobutylHIsobutylIsopropylH
364.MethylIsobutylHIsopropylIsobutylH
365.EthylHHHHH
366.EthylHMethylHHH
367.EthylHHMethylHH
368.EthylHHHMethylH
369.EthylHHHHMethyl
370.EthylHMethylMethylHH
371.EthylHMethylHMethylH
372.EthylHMethylHHMethyl
373.EthylHHMethylMethylH
374.EthylHHMethylHMethyl
375.EthylHHHMethylMethyl
376.EthylHMethylMethylMethylH
377.EthylHMethylMethylHMethyl
378.EthylHMethylHMethylMethyl
379.EthylHHMethylMethylMethyl
380.EthylHMethylMethylMethylMethyl
381.EthylHEthylHHH
382.EthylHHEthylHH
383.EthylHHHEthylH
384.EthylHHHHEthyl
385.EthylHMethylEthylHH
386.EthylHMethylHEthylH
387.EthylHMethylHHEthyl
388.EthylHHEthylMethylH
389.EthylHHEthylEthylH
390.EthylHHMethylEthylH
391.EthylHIsopropylHHH
392.EthylHHIsopropylHH
393.EthylHHHIsopropylH
394.EthylHHHHIsopropyl
395.EthylHMethylIsopropylHH
396.EthylHMethylHIsopropylH
397.EthylHMethylHHIsopropyl
398.EthylHHIsopropylMethylH
399.EthylHHIsopropylIsopropylH
400.EthylHHMethylIsopropylH
401.EthylHHIsopropylEthylH
402.EthylHHEthylIsopropylH
403.EthylHIsobutylHHH
404.EthylHHIsobutylHH
405.EthylHHHIsobutylH
406.EthylHHHHIsobutyl
407.EthylHMethylIsobutylHH
408.EthylHMethylHIsobutylH
409.EthylHMethylHHIsobutyl
410.EthylHHIsobutylMethylH
411.EthylHHIsobutylIsobutylH
412.EthylHHMethylIsobutylH
413.EthylHHIsobutylEthylH
414.EthylHHEthylIsobutylH
415.EthylHHIsobutylIsopropylH
416.EthylHHIsopropylIsobutylH
417.EthylMethylHHHH
418.EthylMethylMethylHHH
419.EthylMethylHMethylHH
420.EthylMethylHHMethylH
421.EthylMethylHHHMethyl
422.EthylMethylMethylMethylHH
423.EthylMethylMethylHMethylH
424.EthylMethylMethylHHMethyl
425.EthylMethylHMethylMethylH
426.EthylMethylHMethylHMethyl
427.EthylMethylHHMethylMethyl
428.EthylMethylMethylMethylMethylH
429.EthylMethylMethylMethylHMethyl
430.EthylMethylMethylHMethylMethyl
431.EthylMethylHMethylMethylMethyl
432.EthylMethylMethylMethylMethylMethyl
433.EthylMethylEthylHHH
434.EthylMethylHEthylHH
435.EthylMethylHHEthylH
436.EthylMethylHHHEthyl
437.EthylMethylMethylEthylHH
438.EthylMethylMethylHEthylH
439.EthylMethylMethylHHEthyl
440.EthylMethylHEthylMethylH
441.EthylMethylHEthylEthylH
442.EthylMethylHMethylEthylH
443.EthylMethylIsopropylHHH
444.EthylMethylHIsopropylHH
445.EthylMethylHHIsopropylH
446.EthylMethylHHHIsopropyl
447.EthylMethylMethylIsopropylHH
448.EthylMethylMethylHIsopropylH
449.EthylMethylMethylHHIsopropyl
450.EthylMethylHIsopropylMethylH
451.EthylMethylHIsopropylIsopropylH
452.EthylMethylHMethylIsopropylH
453.EthylMethylHIsopropylEthylH
454.EthylMethylHEthylIsopropylH
455.EthylMethylIsobutylHHH
456.EthylMethylHIsobutylHH
457.EthylMethylHHIsobutylH
458.EthylMethylHHHIsobutyl
459.EthylMethylMethylIsobutylHH
460.EthylMethylMethylHIsobutylH
461.EthylMethylMethylHHIsobutyl
462.EthylMethylHIsobutylMethylH
463.EthylMethylHIsobutylIsobutylH
464.EthylMethylHMethylIsobutylH
465.EthylMethylHIsobutylEthylH
466.EthylMethylHEthylIsobutylH
467.EthylMethylHIsobutylIsopropylH
468.EthylMethylHIsopropylIsobutylH
469.EthylEthylHHHH
470.EthylEthylMethylHHH
471.EthylEthylHMethylHH
472.EthylEthylHHMethylH
473.EthylEthylHHHMethyl
474.EthylEthylMethylMethylHH
475.EthylEthylMethylHMethylH
476.EthylEthylMethylHHMethyl
477.EthylEthylHMethylMethylH
478.EthylEthylHMethylHMethyl
479.EthylEthylHHMethylMethyl
480.EthylEthylMethylMethylMethylH
481.EthylEthylMethylMethylHMethyl
482.EthylEthylMethylHMethylMethyl
483.EthylEthylHMethylMethylMethyl
484.EthylEthylMethylMethylMethylMethyl
485.EthylEthylEthylHHH
486.EthylEthylHEthylHH
487.EthylEthylHHEthylH
488.EthylEthylHHHEthyl
489.EthylEthylMethylEthylHH
490.EthylEthylMethylHEthylH
491.EthylEthylMethylHHEthyl
492.EthylEthylHEthylMethylH
493.EthylEthylHEthylEthylH
494.EthylEthylHMethylEthylH
495.EthylEthylIsopropylHHH
496.EthylEthylHIsopropylHH
497.EthylEthylHHIsopropylH
498.EthylEthylHHHIsopropyl
499.EthylEthylMethylIsopropylHH
500.EthylEthylMethylHIsopropylH
501.EthylEthylMethylHHIsopropyl
502.EthylEthylHIsopropylMethylH
503.EthylEthylHIsopropylIsopropylH
504.EthylEthylHMethylIsopropylH
505.EthylEthylHIsopropylEthylH
506.EthylEthylHEthylIsopropylH
507.EthylEthylIsobutylHHH
508.EthylEthylHIsobutylHH
509.EthylEthylHHIsobutylH
510.EthylEthylHHHIsobutyl
511.EthylEthylMethylIsobutylHH
512.EthylEthylMethylHIsobutylH
513.EthylEthylMethylHHIsobutyl
514.EthylEthylHIsobutylMethylH
515.EthylEthylHIsobutylIsobutylH
516.EthylEthylHMethylIsobutylH
517.EthylEthylHIsobutylEthylH
518.EthylEthylHEthylIsobutylH
519.EthylEthylHIsobutylIsopropylH
520.EthylEthylHIsopropylIsobutylH
521.EthylIsopropylHHHH
522.EthylIsopropylMethylHHH
523.EthylIsopropylHMethylHH
524.EthylIsopropylHHMethylH
525.EthylIsopropylHHHMethyl
526.EthylIsopropylMethylMethylHH
527.EthylIsopropylMethylHMethylH
528.EthylIsopropylMethylHHMethyl
529.EthylIsopropylHMethylMethylH
530.EthylIsopropylHMethylHMethyl
531.EthylIsopropylHHMethylMethyl
532.EthylIsopropylMethylMethylMethylH
533.EthylIsopropylMethylMethylHMethyl
534.EthylIsopropylMethylHMethylMethyl
535.EthylIsopropylHMethylMethylMethyl
536.EthylIsopropylMethylMethylMethylMethyl
537.EthylIsopropylEthylHHH
538.EthylIsopropylHEthylHH
539.EthylIsopropylHHEthylH
540.EthylIsopropylHHHEthyl
541.EthylIsopropylMethylEthylHH
542.EthylIsopropylMethylHEthylH
543.EthylIsopropylMethylHHEthyl
544.EthylIsopropylHEthylMethylH
545.EthylIsopropylHEthylEthylH
546.EthylIsopropylHMethylEthylH
547.EthylIsopropylIsopropylHHH
548.EthylIsopropylHIsopropylHH
549.EthylIsopropylHHIsopropylH
550.EthylIsopropylHHHIsopropyl
551.EthylIsopropylMethylIsopropylHH
552.EthylIsopropylMethylHIsopropylH
553.EthylIsopropylMethylHHIsopropyl
554.EthylIsopropylHIsopropylMethylH
555.EthylIsopropylHIsopropylIsopropylH
556.EthylIsopropylHMethylIsopropylH
557.EthylIsopropylHIsopropylEthylH
558.EthylIsopropylHEthylIsopropylH
559.EthylIsopropylIsobutylHHH
560.EthylIsopropylHIsobutylHH
561.EthylIsopropylHHIsobutylH
562.EthylIsopropylHHHIsobutyl
563.EthylIsopropylMethylIsobutylHH
564.EthylIsopropylMethylHIsobutylH
565.EthylIsopropylMethylHHIsobutyl
566.EthylIsopropylHIsobutylMethylH
567.EthylIsopropylHIsobutylIsobutylH
568.EthylIsopropylHMethylIsobutylH
569.EthylIsopropylHIsobutylEthylH
570.EthylIsopropylHEthylIsobutylH
571.EthylIsopropylHIsobutylIsopropylH
572.EthylIsopropylHIsopropylIsobutylH
573.EthylIsobutylHHHH
574.EthylIsobutylMethylHHH
575.EthylIsobutylHMethylHH
576.EthylIsobutylHHMethylH
577.EthylIsobutylHHHMethyl
578.EthylIsobutylMethylMethylHH
579.EthylIsobutylMethylHMethylH
580.EthylIsobutylMethylHHMethyl
581.EthylIsobutylHMethylMethylH
582.EthylIsobutylHMethylHMethyl
583.EthylIsobutylHHMethylMethyl
584.EthylIsobutylMethylMethylMethylH
585.EthylIsobutylMethylMethylHMethyl
586.EthylIsobutylMethylHMethylMethyl
587.EthylIsobutylHMethylMethylMethyl
588.EthylIsobutylMethylMethylMethylMethyl
589.EthylIsobutylEthylHHH
590.EthylIsobutylHEthylHH
591.EthylIsobutylHHEthylH
592.EthylIsobutylHHHEthyl
593.EthylIsobutylMethylEthylHH
594.EthylIsobutylMethylHEthylH
595.EthylIsobutylMethylHHEthyl
596.EthylIsobutylHEthylMethylH
597.EthylIsobutylHEthylEthylH
598.EthylIsobutylHMethylEthylH
599.EthylIsobutylIsopropylHHH
600.EthylIsobutylHIsopropylHH
601.EthylIsobutylHHIsopropylH
602.EthylIsobutylHHHIsopropyl
603.EthylIsobutylMethylIsopropylHH
604.EthylIsobutylMethylHIsopropylH
605.EthylIsobutylMethylHHIsopropyl
606.EthylIsobutylHIsopropylMethylH
607.EthylIsobutylHIsopropylIsopropylH
608.EthylIsobutylHMethylIsopropylH
609.EthylIsobutylHIsopropylEthylH
610.EthylIsobutylHEthylIsopropylH
611.EthylIsobutylIsobutylHHH
612.EthylIsobutylHIsobutylHH
613.EthylIsobutylHHIsobutylH
614.EthylIsobutylHHHIsobutyl
615.EthylIsobutylMethylIsobutylHH
616.EthylIsobutylMethylHIsobutylH
617.EthylIsobutylMethylHHIsobutyl
618.EthylIsobutylHIsobutylMethylH
619.EthylIsobutylHIsobutylIsobutylH
620.EthylIsobutylHMethylIsobutylH
621.EthylIsobutylHIsobutylEthylH
622.EthylIsobutylHEthylIsobutylH
623.EthylIsobutylHIsobutylIsopropylH
624.EthylIsobutylHIsopropylIsobutylH
625.IsopropylHHHHH
626.IsopropylHMethylHHH
627.IsopropylHHMethylHH
628.IsopropylHHHMethylH
629.IsopropylHHHHMethyl
630.IsopropylHMethylMethylHH
631.IsopropylHMethylHMethylH
632.IsopropylHMethylHHMethyl
633.IsopropylHHMethylMethylH
634.IsopropylHHMethylHMethyl
635.IsopropylHHHMethylMethyl
636.IsopropylHMethylMethylMethylH
637.IsopropylHMethylMethylHMethyl
638.IsopropylHMethylHMethylMethyl
639.IsopropylHHMethylMethylMethyl
640.IsopropylHMethylMethylMethylMethyl
641.IsopropylHEthylHHH
642.IsopropylHHEthylHH
643.IsopropylHHHEthylH
644.IsopropylHHHHEthyl
645.IsopropylHMethylEthylHH
646.IsopropylHMethylHEthylH
647.IsopropylHMethylHHEthyl
648.IsopropylHHEthylMethylH
649.IsopropylHHEthylEthylH
650.IsopropylHHMethylEthylH
651.IsopropylHIsopropylHHH
652.IsopropylHHIsopropylHH
653.IsopropylHHHIsopropylH
654.IsopropylHHHHIsopropyl
655.IsopropylHMethylIsopropylHH
656.IsopropylHMethylHIsopropylH
657.IsopropylHMethylHHIsopropyl
658.IsopropylHHIsopropylMethylH
659.IsopropylHHIsopropylIsopropylH
660.IsopropylHHMethylIsopropylH
661.IsopropylHHIsopropylEthylH
662.IsopropylHHEthylIsopropylH
663.IsopropylHIsobutylHHH
664.IsopropylHHIsobutylHH
665.IsopropylHHHIsobutylH
666.IsopropylHHHHIsobutyl
667.IsopropylHMethylIsobutylHH
668.IsopropylHMethylHIsobutylH
669.IsopropylHMethylHHIsobutyl
670.IsopropylHHIsobutylMethylH
671.IsopropylHHIsobutylIsobutylH
672.IsopropylHHMethylIsobutylH
673.IsopropylHHIsobutylEthylH
674.IsopropylHHEthylIsobutylH
675.IsopropylHHIsobutylIsopropylH
676.IsopropylHHIsopropylIsobutylH
677.IsopropylMethylHHHH
678.IsopropylMethylMethylHHH
679.IsopropylMethylHMethylHH
680.IsopropylMethylHHMethylH
681.IsopropylMethylHHHMethyl
682.IsopropylMethylMethylMethylHH
683.IsopropylMethylMethylHMethylH
684.IsopropylMethylMethylHHMethyl
685.IsopropylMethylHMethylMethylH
686.IsopropylMethylHMethylHMethyl
687.IsopropylMethylHHMethylMethyl
688.IsopropylMethylMethylMethylMethylH
689.IsopropylMethylMethylMethylHMethyl
690.IsopropylMethylMethylHMethylMethyl
691.IsopropylMethylHMethylMethylMethyl
692.IsopropylMethylMethylMethylMethylMethyl
693.IsopropylMethylEthylHHH
694.IsopropylMethylHEthylHH
695.IsopropylMethylHHEthylH
696.IsopropylMethylHHHEthyl
697.IsopropylMethylMethylEthylHH
698.IsopropylMethylMethylHEthylH
699.IsopropylMethylMethylHHEthyl
700.IsopropylMethylHEthylMethylH
701.IsopropylMethylHEthylEthylH
702.IsopropylMethylHMethylEthylH
703.IsopropylMethylIsopropy1HHH
704.IsopropylMethylHIsopropylHH
705.IsopropylMethylHHIsopropylH
706.IsopropylMethylHHHIsopropyl
707.IsopropylMethylMethylIsopropylHH
708.IsopropylMethylMethylHIsopropylH
709.IsopropylMethylMethylHHIsopropyl
710.IsopropylMethylHIsopropylMethylH
711.IsopropylMethylHIsopropylIsopropylH
712.IsopropylMethylHMethylIsopropylH
713.IsopropylMethylHIsopropylEthylH
714.IsopropylMethylHEthylIsopropylH
715.IsopropylMethylIsobutylHHH
716.IsopropylMethylHIsobutylHH
717.IsopropylMethylHHIsobutylH
718.IsopropylMethylHHHIsobutyl
719.IsopropylMethylMethylIsobutylHH
720.IsopropylMethylMethylHIsobutylH
721.IsopropylMethylMethylHHIsobutyl
722.IsopropylMethylHIsobutylMethylH
723.IsopropylMethylHIsobutylIsobutylH
724.IsopropylMethylHMethylIsobutylH
725.IsopropylMethylHIsobutylEthylH
726.IsopropylMethylHEthylIsobutylH
727.IsopropylMethylHIsobutylIsopropylH
728.IsopropylMethylHIsopropylIsobutylH
729.IsopropylEthylHHHH
730.IsopropylEthylMethylHHH
731.IsopropylEthylHMethylHH
732.IsopropylEthylHHMethylH
733.IsopropylEthylHHHMethyl
734.IsopropylEthylMethylMethylHH
735.IsopropylEthylMethylHMethylH
736.IsopropylEthylMethylHHMethyl
737.IsopropylEthylHMethylMethylH
738.IsopropylEthylHMethylHMethyl
739.IsopropylEthylHHMethylMethyl
740.IsopropylEthylMethylMethylMethylH
741.IsopropylEthylMethylMethylHMethyl
742.IsopropylEthylMethylHMethylMethyl
743.IsopropylEthylHMethylMethylMethyl
744.IsopropylEthylMethylMethylMethylMethyl
745.IsopropylEthylEthylHHH
746.IsopropylEthylHEthylHH
747.IsopropylEthylHHEthylH
748.IsopropylEthylHHHEthyl
749.IsopropylEthylMethylEthylHH
750.IsopropylEthylMethylHEthylH
751.IsopropylEthylMethylHHEthyl
752.IsopropylEthylHEthylMethylH
753.IsopropylEthylHEthylEthylH
754.IsopropylEthylHMethylEthylH
755.IsopropylEthylIsopropylHHH
756.IsopropylEthylHIsopropylHH
757.IsopropylEthylHHIsopropylH
758.IsopropylEthylHHHIsopropyl
759.IsopropylEthylMethylIsopropylHH
760.IsopropylEthylMethylHIsopropylH
761.IsopropylEthylMethylHHIsopropyl
762.IsopropylEthylHIsopropylMethylH
763.IsopropylEthylHIsopropylIsopropylH
764.IsopropylEthylHMethylIsopropylH
765.IsopropylEthylHIsopropylEthylH
766.IsopropylEthylHEthylIsopropylH
767.IsopropylEthylIsobutylHHH
768.IsopropylEthylHIsobutylHH
769.IsopropylEthylHHIsobutylH
770.IsopropylEthylHHHIsobutyl
771.IsopropylEthylMethylIsobutylHH
772.IsopropylEthylMethylHIsobutylH
773.IsopropylEthylMethylHHIsobutyl
774.IsopropylEthylHIsobutylMethylH
775.IsopropylEthylHIsobutylIsobutylH
776.IsopropylEthylHMethylIsobutylH
777.IsopropylEthylHIsobutylEthylH
778.IsopropylEthylHEthylIsobutylH
779.IsopropylEthylHIsobutylIsopropylH
780.IsopropylEthylHIsopropylIsobutylH
781.IsopropylIsopropylHHHH
782.IsopropylIsopropylMethylHHH
783.IsopropylIsopropylHMethylHH
784.IsopropylIsopropylHHMethylH
785.IsopropylIsopropylHHHMethyl
786.IsopropylIsopropylMethylMethylHH
787.IsopropylIsopropylMethylHMethylH
788.IsopropylIsopropylMethylHHMethyl
789.IsopropylIsopropylHMethylMethylH
790.IsopropylIsopropylHMethylHMethyl
791.IsopropylIsopropylHHMethylMethyl
792.IsopropylIsopropylMethylMethylMethylH
793.IsopropylIsopropylMethylMethylHMethyl
794.IsopropylIsopropylMethylHMethylMethyl
795.IsopropylIsopropylHMethylMethylMethyl
796.IsopropylIsopropylMethylMethylMethylMethyl
797.IsopropylIsopropylEthylHHH
798.IsopropylIsopropylHEthylHH
799.IsopropylIsopropylHHEthylH
800.IsopropylIsopropylHHHEthyl
801.IsopropylIsopropylMethylEthylHH
802.IsopropylIsopropylMethylHEthylH
803.IsopropylIsopropylMethylHHEthyl
804.IsopropylIsopropylHEthylMethylH
805.IsopropylIsopropylHEthylEthylH
806.IsopropylIsopropylHMethylEthylH
807.IsopropylIsopropylIsopropylHHH
808.IsopropylIsopropylHIsopropylHH
809.IsopropylIsopropylHHIsopropylH
810.IsopropylIsopropylHHHIsopropyl
811.IsopropylIsopropylMethylIsopropylHH
812.IsopropylIsopropylMethylHIsopropylH
813.IsopropylIsopropylMethylHHIsopropyl
814.IsopropylIsopropylHIsopropylMethylH
815.IsopropylIsopropylHIsopropylIsopropylH
816.IsopropylIsopropylHMethylIsopropylH
817.IsopropylIsopropylHIsopropylEthylH
818.IsopropylIsopropylHEthylIsopropylH
819.IsopropylIsopropylIsobutylHHH
820.IsopropylIsopropylHIsobutylHH
821.IsopropylIsopropylHHIsobutylH
822.IsopropylIsopropylHHHIsobutyl
823.IsopropylIsopropylMethylIsobutylHH
824.IsopropylIsopropylMethylHIsobutylH
825.IsopropylIsopropylMethylHHIsobutyl
826.IsopropylIsopropylHIsobutylMethylH
827.IsopropylIsopropylHIsobutylIsobutylH
828.IsopropylIsopropylHMethylIsobutylH
829.IsopropylIsopropylHIsobutylEthylH
830.IsopropylIsopropylHEthylIsobutylH
831.IsopropylIsopropylHIsobutylIsopropylH
832.IsopropylIsopropylHIsopropylIsobutylH
833.IsopropylIsobutylHHHH
834.IsopropylIsobutylMethylHHH
835.IsopropylIsobutylHMethylHH
836.IsopropylIsobutylHHMethylH
837.IsopropylIsobutylHHHMethyl
838.IsopropylIsobutylMethylMethylHH
839.IsopropylIsobutylMethylHMethylH
840.IsopropylIsobutylMethylHHMethyl
841.IsopropylIsobutylHMethylMethylH
842.IsopropylIsobutylHMethylHMethyl
843.IsopropylIsobutylHHMethylMethyl
844.IsopropylIsobutylMethylMethylMethylH
845.IsopropylIsobutylMethylMethylHMethyl
846.IsopropylIsobutylMethylHMethylMethyl
847.IsopropylIsobutylHMethylMethylMethyl
848.IsopropylIsobutylMethylMethylMethylMethyl
849.IsopropylIsobutylEthylHHH
850.IsopropylIsobutylHEthylHH
851.IsopropylIsobutylHHEthylH
852.IsopropylIsobutylHHHEthyl
853.IsopropylIsobutylMethylEthylHH
854.IsopropylIsobutylMethylHEthylH
855.IsopropylIsobutylMethylHHEthyl
856.IsopropylIsobutylHEthylMethylH
857.IsopropylIsobutylHEthylEthylH
858.IsopropylIsobutylHMethylEthylH
859.IsopropylIsobutylIsopropylHHH
860.IsopropylIsobutylHIsopropylHH
861.IsopropylIsobutylHHIsopropylH
862.IsopropylIsobutylHHHIsopropyl
863.IsopropylIsobutylMethylIsopropylHH
864.IsopropylIsobutylMethylHIsopropylH
865.IsopropylIsobutylMethylHHIsopropyl
866.IsopropylIsobutylHIsopropylMethylH
867.IsopropylIsobutylHIsopropylIsopropylH
868.IsopropylIsobutylHMethylIsopropylH
869.IsopropylIsobutylHIsopropylEthylH
870.IsopropylIsobutylHEthylIsopropylH
871.IsopropylIsobutylIsobutylHHH
872.IsopropylIsobutylHIsobutylHH
873.IsopropylIsobutylHHIsobutylH
874.IsopropylIsobutylHHHIsobutyl
875.IsopropylIsobutylMethylIsobutylHH
876.IsopropylIsobutylMethylHIsobutylH
877.IsopropylIsobutylMethylHHIsobutyl
878.IsopropylIsobutylHIsobutylMethylH
879.IsopropylIsobutylHIsobutylIsobutylH
880.IsopropylIsobutylHMethylIsobutylH
881.IsopropylIsobutylHIsobutylEthylH
882.IsopropylIsobutylHEthylIsobutylH
883.IsopropylIsobutylHIsobutylIsopropylH
884.IsopropylIsobutylHIsopropylIsobutylH
885.IsobutylHHHHH
886.IsobutylHMethylHHH
887.IsobutylHHMethylHH
888.IsobutylHHHMethylH
889.IsobutylHHHHMethyl
890.IsobutylHMethylMethylHH
891.IsobutylHMethylHMethylH
892.IsobutylHMethylHHMethyl
893.IsobutylHHMethylMethylH
894.IsobutylHHMethylHMethyl
895.IsobutylHHHMethylMethyl
896.IsobutylHMethylMethylMethylH
897.IsobutylHMethylMethylHMethyl
898.IsobutylHMethylHMethylMethyl
899.IsobutylHHMethylMethylMethyl
900.IsobutylHMethylMethylMethylMethyl
901.IsobutylHEthylHHH
902.IsobutylHHEthylHH
903.IsobutylHHHEthylH
904.IsobutylHHHHEthyl
905.IsobutylHMethylEthylHH
906.IsobutylHMethylHEthylH
907.IsobutylHMethylHHEthyl
908.IsobutylHHEthylMethylH
909.IsobutylHHEthylEthylH
910.IsobutylHHMethylEthylH
911.IsobutylHIsopropylHHH
912.IsobutylHHIsopropylHH
913.IsobutylHHHIsopropylH
914.IsobutylHHHHIsopropyl
915.IsobutylHMethylIsopropylHH
916.IsobutylHMethylHIsopropylH
917.IsobutylHMethylHHIsopropyl
918.IsobutylHHIsopropylMethylH
919.IsobutylHHIsopropylIsopropylH
920.IsobutylHHMethylIsopropylH
921.IsobutylHHIsopropylEthylH
922.IsobutylHHEthylIsopropylH
923.IsobutylHIsobutylHHH
924.IsobutylHHIsobutylHH
925.IsobutylHHHIsobutylH
926.IsobutylHHHHIsobutyl
927.IsobutylHMethylIsobutylHH
928.IsobutylHMethylHIsobutylH
929.IsobutylHMethylHHIsobutyl
930.IsobutylHHIsobutylMethylH
931.IsobutylHHIsobutylIsobutylH
932.IsobutylHHMethylIsobutylH
933.IsobutylHHIsobutylEthylH
934.IsobutylHHEthylIsobutylH
935.IsobutylHHIsobutylIsopropylH
936.IsobutylHHIsopropylIsobutylH
937.IsobutylMethylHHHH
938.IsobutylMethylMethylHHH
939.IsobutylMethylHMethylHH
940.IsobutylMethylHHMethylH
941.IsobutylMethylHHHMethyl
942.IsobutylMethylMethylMethylHH
943.IsobutylMethylMethylHMethylH
944.IsobutylMethylMethylHHMethyl
945.IsobutylMethylHMethylMethylH
946.IsobutylMethylHMethylHMethyl
947.IsobutylMethylHHMethylMethyl
948.IsobutylMethylMethylMethylMethylH
949.IsobutylMethylMethylMethylHMethyl
950.IsobutylMethylMethylHMethylMethyl
951.IsobutylMethylHMethylMethylMethyl
952.IsobutylMethylMethylMethylMethylMethyl
953.IsobutylMethylEthylHHH
954.IsobutylMethylHEthylHH
955.IsobutylMethylHHEthylH
956.IsobutylMethylHHHEthyl
957.IsobutylMethylMethylEthylHH
958.IsobutylMethylMethylHEthylH
959.IsobutylMethylMethylHHEthyl
960.IsobutylMethylHEthylMethylH
961.IsobutylMethylHEthylEthylH
962.IsobutylMethylHMethylEthylH
963.IsobutylMethylIsopropylHHH
964.IsobutylMethylHIsopropylHH
965.IsobutylMethylHHIsopropylH
966.IsobutylMethylHHHIsopropyl
967.IsobutylMethylMethylIsopropylHH
968.IsobutylMethylMethylHIsopropylH
969.IsobutylMethylMethylHHIsopropyl
970.IsobutylMethylHIsopropylMethylH
971.IsobutylMethylHIsopropylIsopropylH
972.IsobutylMethylHMethylIsopropylH
973.IsobutylMethylHIsopropylEthylH
974.IsobutylMethylHEthylIsopropylH
975.IsobutylMethylIsobutylHHH
976.IsobutylMethylHIsobutylHH
977.IsobutylMethylHHIsobutylH
978.IsobutylMethylHHHIsobutyl
979.IsobutylMethylMethylIsobutylHH
980.IsobutylMethylMethylHIsobutylH
981.IsobutylMethylMethylHHIsobutyl
982.IsobutylMethylHIsobutylMethylH
983.IsobutylMethylHIsobutylIsobutylH
984.IsobutylMethylHMethylIsobutylH
985.IsobutylMethylHIsobutylEthylH
986.IsobutylMethylHEthylIsobutylH
987.IsobutylMethylHIsobutylIsopropylH
988.IsobutylMethylHIsopropylIsobutylH
989.IsobutylEthylHHHH
990.IsobutylEthylMethylHHH
991.IsobutylEthylHMethylHH
992.IsobutylEthylHHMethylH
993.IsobutylEthylHHHMethyl
994.IsobutylEthylMethylMethylHH
995.IsobutylEthylMethylHMethylH
996.IsobutylEthylMethylHHMethyl
997.IsobutylEthylHMethylMethylH
998.IsobutylEthylHMethylHMethyl
999.IsobutylEthylHHMethylMethyl
1000.IsobutylEthylMethylMethylMethylH
1001.IsobutylEthylMethylMethylHMethyl
1002.IsobutylEthylMethylHMethylMethyl
1003.IsobutylEthylHMethylMethylMethyl
1004.IsobutylEthylMethylMethylMethylMethyl
1005.IsobutylEthylEthylHHH
1006.IsobutylEthylHEthylHH
1007.IsobutylEthylHHEthylH
1008.IsobutylEthylHHHEthyl
1009.IsobutylEthylMethylEthylHH
1010.IsobutylEthylMethylHEthylH
1011.IsobutylEthylMethylHHEthyl
1012.IsobutylEthylHEthylMethylH
1013.IsobutylEthylHEthylEthylH
1014.IsobutylEthylHMethylEthylH
1015.IsobutylEthylIsopropylHHH
1016.IsobutylEthylHIsopropylHH
1017.IsobutylEthylHHIsopropylH
1018.IsobutylEthylHHHIsopropyl
1019.IsobutylEthylMethylIsopropylHH
1020.IsobutylEthylMethylHIsopropylH
1021.IsobutylEthylMethylHHIsopropyl
1022.IsobutylEthylHIsopropylMethylH
1023.IsobutylEthylHIsopropylIsopropylH
1024.IsobutylEthylHMethylIsopropylH
1025.IsobutylEthylHIsopropylEthylH
1026.IsobutylEthylHEthylIsopropylH
1027.IsobutylEthylIsobutylHHH
1028.IsobutylEthylHIsobutylHH
1029.IsobutylEthylHHIsobutylH
1030.IsobutylEthylHHHIsobutyl
1031.IsobutylEthylMethylIsobutylHH
1032.IsobutylEthylMethylHIsobutylH
1033.IsobutylEthylMethylHHIsobutyl
1034.IsobutylEthylHIsobutylMethylH
1035.IsobutylEthylHIsobutylIsobutylH
1036.IsobutylEthylHMethylIsobutylH
1037.IsobutylEthylHIsobutylEthylH
1038.IsobutylEthylHEthylIsobutylH
1039.IsobutylEthylHIsobutylIsopropylH
1040.IsobutylEthylHIsopropylIsobutylH
1041.IsobutylIsopropylHHHH
1042.IsobutylIsopropylMethylHHH
1043.IsobutylIsopropylHMethylHH
1044.IsobutylIsopropylHHMethylH
1045.IsobutylIsopropylHHHMethyl
1046.IsobutylIsopropylMethylMethylHH
1047.IsobutylIsopropylMethylHMethylH
1048.IsobutylIsopropylMethylHHMethyl
1049.IsobutylIsopropylHMethylMethylH
1050.IsobutylIsopropylHMethylHMethyl
1051.IsobutylIsopropylHHMethylMethyl
1052.IsobutylIsopropylMethylMethylMethylH
1053.IsobutylIsopropylMethylMethylHMethyl
1054.IsobutylIsopropylMethylHMethylMethyl
1055.IsobutylIsopropylHMethylMethylMethyl
1056.IsobutylIsopropylMethylMethylMethylMethyl
1057.IsobutylIsopropylEthylHHH
1058.IsobutylIsopropylHEthylHH
1059.IsobutylIsopropylHHEthylH
1060.IsobutylIsopropylHHHEthyl
1061.IsobutylIsopropylMethylEthylHH
1062.IsobutylIsopropylMethylHEthylH
1063.IsobutylIsopropylMethylHHEthyl
1064.IsobutylIsopropylHEthylMethylH
1065.IsobutylIsopropylHEthylEthylH
1066.IsobutylIsopropylHMethylEthylH
1067.IsobutylIsopropylIsopropylHHH
1068.IsobutylIsopropylHIsopropylHH
1069.IsobutylIsopropylHHIsopropylH
1070.IsobutylIsopropylHHHIsopropyl
1071.IsobutylIsopropylMethylIsopropylHH
1072.IsobutylIsopropylMethylHIsopropylH
1073.IsobutylIsopropylMethylHHIsopropyl
1074.IsobutylIsopropylHIsopropylMethylH
1075.IsobutylIsopropylHIsopropylIsopropylH
1076.IsobutylIsopropylHMethylIsopropylH
1077.IsobutylIsopropylHIsopropylEthylH
1078.IsobutylIsopropylHEthylIsopropylH
1079.IsobutylIsopropylIsobutylHHH
1080.IsobutylIsopropylHIsobutylHH
1081.IsobutylIsopropylHHIsobutylH
1082.IsobutylIsopropylHHHIsobutyl
1083.IsobutylIsopropylMethylIsobutylHH
1084.IsobutylIsopropylMethylHIsobutylH
1085.IsobutylIsopropylMethylHHIsobutyl
1086.IsobutylIsopropylHIsobutylMethylH
1087.IsobutylIsopropylHIsobutylIsobutylH
1088.IsobutylIsopropylHMethylIsobutylH
1089.IsobutylIsopropylHIsobutylEthylH
1090.IsobutylIsopropylHEthylIsobutylH
1091.IsobutylIsopropylHIsobutylIsopropylH
1092.IsobutylIsopropylHIsopropylIsobutylH
1093.IsobutylIsobutylHHHH
1094.IsobutylIsobutylMethylHHH
1095.IsobutylIsobutylHMethylHH
1096.IsobutylIsobutylHHMethylH
1097.IsobutylIsobutylHHHMethyl
1098.IsobutylIsobutylMethylMethylHH
1099.IsobutylIsobutylMethylHMethylH
1100.IsobutylIsobutylMethylHHMethyl
1101.IsobutylIsobutylHMethylMethylH
1102.IsobutylIsobutylHMethylHMethyl
1103.IsobutylIsobutylHHMethylMethyl
1104.IsobutylIsobutylMethylMethylMethylH
1105.IsobutylIsobutylMethylMethylHMethyl
1106.IsobutylIsobutylMethylHMethylMethyl
1107.IsobutylIsobutylHMethylMethylMethyl
1108.IsobutylIsobutylMethylMethylMethylMethyl
1109.IsobutylIsobutylEthylHHH
1110.IsobutylIsobutylHEthylHH
1111.IsobutylIsobutylHHEthylH
1112.IsobutylIsobutylHHHEthyl
1113.IsobutylIsobutylMethylEthylHH
1114.IsobutylIsobutylMethylHEthylH
1115.IsobutylIsobutylMethylHHEthyl
1116.IsobutylIsobutylHEthylMethylH
1117.IsobutylIsobutylHEthylEthylH
1118.IsobutylIsobutylHMethylEthylH
1119.IsobutylIsobutylIsopropylHHH
1120.IsobutylIsobutylHIsopropylHH
1121.IsobutylIsobutylHHIsopropylH
1122.IsobutylIsobutylHHHIsopropyl
1123.IsobutylIsobutylMethylIsopropylHH
1124.IsobutylIsobutylMethylHIsopropylH
1125.IsobutylIsobutylMethylHHIsopropyl
1126.IsobutylIsobutylHIsopropylMethylH
1127.IsobutylIsobutylHIsopropylIsopropylH
1128.IsobutylIsobutylHMethylIsopropylH
1129.IsobutylIsobutylHIsopropylEthylH
1130.IsobutylIsobutylHEthylIsopropylH
1131.IsobutylIsobutylIsobutylHHH
1132.IsobutylIsobutylHIsobutylHH
1133.IsobutylIsobutylHHIsobutylH
1134.IsobutylIsobutylHHHIsobutyl
1135.IsobutylIsobutylMethylIsobutylHH
1136.IsobutylIsobutylMethylHIsobutylH
1137.IsobutylIsobutylMethylHHIsobutyl
1138.IsobutylIsobutylHIsobutylMethylH
1139.IsobutylIsobutylHIsobutylIsobutylH
1140.IsobutylIsobutylHMethylIsobutylH
1141.IsobutylIsobutylHIsobutylEthylH
1142.IsobutylIsobutylHEthylIsobutylH
1143.IsobutylIsobutylHIsobutylIsopropylH
1144.IsobutylIsobutylHIsopropylIsobutylH
1145.CD 3 CH 2HHHHH
1146.(CD 3 ) 2 CHHHHHH
TABLE 2 — VTE Phosphorescent OLEDs
ExampleHILHTLEML (300 Å, doping %)BLETL 1
ComparativeCompound CNPD 300 ÅCompoundCompound ACompound DAlq 400Å
Example 1100 ÅD10%50 Å
ComparativeCompound CNPD 300 ÅCompoundCompound BCompound DAlq 400Å
Example 2100 ÅD10%50 Å
Example 1Compound CNPD 300 ÅCompoundCompound 53Compound DAlq 400Å
100 ÅD12%50 Å
Example 2Compound CNPD 300 ÅCompoundCompound 157Compound DAlq 400Å
100 ÅD10%50 Å
Example 3Compound CNPD 300 ÅCompoundCompound 158Compound DAlq 400Å
100 ÅD12%50 Å
Example 4Compound CNPD 300 ÅCompoundCompound 159Compound DAlq 400 Å
100 ÅD10%50 Å
Example 5Compound CNPD 300 ÅCompoundCompound 165Compound DAlq 400 Å
100 ÅD12%50 Å
Example 6Compound CNPD 300 ÅCompoundCompound 174Compound DAlq 400 Å
100 ÅD8%50 Å
Example 7Compound CNPD 300 ÅCompoundCompound 175Compound DAlq 400 Å
100 ÅD8%50 Å
Example 8Compound CNPD 300 ÅCompoundCompound 184Compound DAlq 400 Å
100 ÅD7%50 Å
Example 9Compound CNPD 300 ÅCompoundCompound 185Compound DAlq 400 Å
100 ÅD10%50 Å
Example 10Compound CNPD 300 ÅCompoundCompound 314Compound DAlq 400 Å
100 ÅD12%50 Å
Example 11Compound CNPD 300 ÅCompoundCompound 321Compound DAlq 400 Å
100 ÅD12%50 Å
Example 12Compound CNPD 300 ÅCompoundCompound 625Compound DAlq 400 Å
100 ÅD12%50 Å
Example 13Compound CNPD 300 ÅCompoundCompound 626Compound DAlq 400 Å
100 ÅD10%50 Å
Example 14Compound CNPD 300 ÅCompoundCompound 627Compound DAlq 400 Å
100 ÅD8%50 Å
Example 15Compound CNPD 300 ÅCompoundCompound 628Compound DAlq 400 Å
100 ÅD8%50 Å
Example 16Compound CNPD 300 ÅCompoundCompound 633Compound DAlq 400 Å
100 ÅD10%50 Å
Example 17Compound CNPD 300 ÅCompoundCompound 643Compound DAlq 400 Å
100 ÅD8%50 Å
Example 18Compound CNPD 300 ÅCompoundCompound 652Compound DAlq 400 Å
100 ÅD8%50 Å
Example 19Compound CNPD 300 ÅCompoundCompound 653Compound DAlq 400 Å
100 ÅD8%50 Å
Example 20Compound CNPD 300 ÅCompoundCompound 1145Compound DAlq 400 Å
100 ÅD10%50 Å
Example 21Compound CNPD 300 ÅCompoundCompound 1146Compound DAlq 400 Å
100 ÅD10%50 Å
TABLE 3 — VTE Device Data
λ maxFWHMVoltageLEEQEPELT80%
xy(nm)(nm)(V)(Cd/A)(%)(lm/W)(h)
Comparative0.3670.607532666.543.211.521250
Example 1
Compound A
Comparative0.3360.623524665.258.215.735170
Example 2
Compound B
Example 10.3450.619526645.169.218.742.720
Compound 53
Example 20.3360.618518705.862.217.333.6166
Compound 157
Example 30.3180.632518604.773.420.249.155
Compound 158
Example 40.3390.616520665.458.316.233.982
Compound 159
Example 50.3330.626522624.656.115.238.354
Compound 165
Example 60.3270.627520644.961.516.939.362
Compound 174
Example 70.3140.635518605.371.219.542.277
Compound 175
Example 80.3310.623518645.752.814.628.866
Compound 184
Example 90.3310.623518645.456.715.732.953
Compound 185
Example 100.3080.636516605.061.416.938.944
Compound 314
Example 110.3260.630520605.161.416.637.773
Compound 321
Example 120.3380.622524665.160.116.337.2124
Compound 625
Example 130.3360.624522645.567.418.238.271
Compound 626
Example 140.3450.619526645.265.217.739.2121
Compound 627
Example 150.3510.615526645.668.618.638.7124
Compound 628
Example 160.3660.608528665.066.317.841.856
Compound 633
Example 170.3390.625526605.271.519.143.3108
Compound 643
Example 180.3490.616526665.753.414.529.3104
Compound 652
Example 190.3370.626524625.165.617.640.884
Compound 653
Example 200.3430.618524685.661.316.734.459
Compound 1145
Example 210.3430.618524685.66317.235.5157
Compound 1146
1 of 21 part labels are ours — the grant heads the rest

Claims as granted

17 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

7 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C09K11/06
Section H — Electricity
  • H10K99/00
USPC · US Patent Classification
428/690546/4428/917313/504257/E51.044

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJul 2011Jan 2012Jul 2012Jan 2013Jul 2013Jan 2014Jul 2014USPTOApplicantNon-final rejectionResponse after non-finalApplicant-initiated interviewNon-final rejectionResponse after non-final
USPTOApplicanthover for detail · click to open
Pendency
2.8 y
1,006 days filing → grant
Office actions
3
non-final + final
Responses
2
1 RCE
Interviews
1
examiner interview summaries
Examiner
Marie R. Yamnitzky
art unit 1786 · TC 1700
Citations: 177 back · 36 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom20122014201620182020202220242026202820302032Owner 1
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock